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ABSTRACT OF DISSERTATION 
NOVEL ROLE OF INTESTINAL LIPID TRANSPORT IN FOOD ALLERGY AND 
CHOLESTEROL HOMEOSTASIS 
The small intestine is the main organ for food digestion and nutrient absorption. It is constantly 
exposed to antigen and immunomodulatory agents from diet and commensal microbiota. Thus, 
the intestine is the largest compartment of the immune system in the body. Peanuts and many 
other allergen resources contain triglycerides, which may affect the antigen absorption through 
the intestine, but their effects on sensitization and anaphylaxis are unknown. We found that 
medium chain triglycerides (MCT) promoted antigen absorption into Peyer’s Patches, rather 
than into the blood directly. Both gavage and feeding of MCT plus peanut protein induced 
spontaneous allergic sensitization. MCT-sensitized mice experienced the IgG-dependent 
anaphylaxis from systemic challenges and the IgE-dependent anaphylaxis from oral challenges. 
Furthermore, MCT alone had direct pharmaceutical effect on enterocytes, like stimulating 
Jejunal-epithelial Th2 cytokine responses compared with what was seen in the long chain 
triglycerides (LCT) treated group. Moreover, the oral challenges conducted with peanut protein 
in MCT significantly exacerbated anaphylaxis compared with the LCT challenges.  
The intestine also plays an important role in whole body cholesterol homeostasis due to its 
exclusive function in cholesterol absorption. The researchers found that the intestine function in 
cholesterol secretion and elimination, but it has not been proven directly until recently. This 
pathway that facilitates the cholesterol secretions through intestine was named the 
Transintestinal Cholesterol Efflux (TICE) and has not been well studied yet.  
To find the possible transporter candidates involved in TICE, we compared both biliary and 
intestinal cholesterol excretion rates in wild-type (WT) and G5G8 deficient (KO) mice of both 
sexes. All mice were maintained on a plant-sterol free diet beginning at weaning to prevent the 
development of secondary phenotypes associated with Sitosterolemia. We found that WT mice 
had higher biliary cholesterol excretion rates compared to their G5G8 KO littermates as 
previously reported. However, this difference is significantly greater in females compared to 
males. Interestingly, intestinal cholesterol excretions increased in female KO mice compared to 
their WT littermates, a difference not observed in males. This data suggests a sexually dimorphic 
adaptive mechanism to maintain cholesterol elimination in the absence of G5G8. Whereas male 
mice maintain a greater level of biliary output in the absence of G5G8, female mice upregulate 
an alternate intestinal elimination route.  
To determine the origin of intestinally secreted cholesterol, we compared both hepatobiliary 
and intestinal cholesterol secretion rates in male wild-type (WT) and CETP transgenic (CETP TG) 
mice at the age of 12 weeks. Cholesteryl ester transfer protein (CETP) facilitates the transport of 
cholesteryl esters and triglycerides between lipoproteins in plasma and alters the lipoprotein 
distribution of plasma cholesterol. We found that WT and CETP TG mice did not differ in either 
biliary or intestinal cholesterol secretion rates when maintained on a standard chow diet. 
However, CETP TG mice showed increased biliary cholesterol secretion rates and decreased 
intestinal cholesterol secretion rates compared to the WT group in response to a Western diet. 
We next determined the effect of CETP on the delivery of radiolabeled HDL-cholesterol ester to 
bile and intestinal lumen. Unlike bulk cholesterol secretions, HDL-derived cholesterol esters 
were preferentially delivered to the intestine in CETP TG mice. This data suggests that CETP alter 
the routes of total and HDL cholesterol elimination from the body in mice. 
Jianing Li 
7-7-2015 
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CHAPTER I. BACKGOUND 
1.1 Small intestine and its physiological functions 
1.1.1 Small intestine[1] 
The small and large intestines represent the continuous tube system connecting the outlet 
of the stomach to the anus. The small intestine contains the part from the pylorus to the 
ileocaecal valve, which is the entry point to the large intestine. The small intestine can be 
divided into three main segments. The duodenum is the closest to the stomach, followed by the 
jejunum and the ileum. The small intestine is characterized by villi, finger-like projections which 
extend into the lumen and increase the active digestive epithelium surface area. In the opposite, 
caecum and colon lack villi and their surfaces are flat. In all parts of intestine, the surface 
epithelium is renewed continuously by multipotent stem cells arising from crypts of Lieberkϋhn. 
These cells are comprised of absorptive enterocytes, but also Paneth cells, goblet cells and 
neuroendocrine cells. Paneth cells migrate downwards to the base of the crypt, while the other 
newly formed cells move from bottom of the crypt to the tip of the villus, followed by extrusion 
after 4-5 days. During this process, the epithelial cells acquire the majority of enzymes and other 
properties needed for digestion and absorptive functions as they reach the base of the villus. 
The different regions of intestine have distinct physiological functions. The surface of 
absorptive epithelial cells in the small intestine is covered by a layer of microvilli where the 
majority of digestive enzymes are located, as well as nutrient transporters (Figure 1). The  
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Figure 1.1. Anatomy of the intestinal mucosa and its immune apparatus[1]. 
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‘brush border’ increases the surface area for digestion on the basis of long villi in the duodenum 
and jejunum. Most protein, carbohydrates and lipids digestions occur in this upper part of 
intestine. Damage to the upper small intestine leads to severe malabsorption, protein leakage 
and malnutrition. Compared to upper intestine, ileum mainly absorb bile salts and vitamin B12, 
contributing less to nutrition absorption and has remarkably shorter villi and lower levels of 
brush border enzymes[1]. 
1.1.2 Role of small intestine in immunology[1] and food allergy 
1.1.2.1 Role of small intestine in immunology 
The epithelium, the underlying lamina propria and the muscularis mucosa, a thin muscle 
layer below the lamina propria, comprise the mucosa, where most immunological processes 
occur (Figure 1). Lamina propria consists of connective tissues, blood supply, lymph drainage, 
nervous supply for the mucosa and also many cells from innate and adaptive immune systems. 
The lamina propria and epithelium form very distinct immunological compartments. The 
organized structures of the Gut Associated Lymphoid Tissue (GALT) that comprises subepithelia 
lymphoid and lies in the mucosa and the mesenteric lymph nodes are the primary locations for 
priming adaptive immune cell responses in the intestine. Effector immune cells are distributed 
throughout the lamina propria. 
GALT is characterized by being covered by follicle-associated epithelium which contains 
Microfold cell (M cells). M cells uptake and transport particular antigens from lumen into 
subepithelial dome (SED) region which is rich in dendritic cell (DC), where they can be presented 
to adaptive immune cells by antigen presenting cells (APC). Peyer’s patches are the best-
characterized tissues in GALT and locate on the outside of small intestine. Peyer’s patches are 
found mostly in the ileum, less in jejunum and barely found in duodenum[2]. There are great 
amount of B cell lymphoid follicles surrounded by smaller T cell areas in Peyer’s patches. 
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Different from lymph nodes, Peyer’s patches do not have complete capsule structures and 
contain germinal centers always, indicating of continual immune stimulation mainly in response 
to antigen from intestinal lumen. With the same reason, the intestinal (mesenteric) lymph nodes 
draining are the largest in the body.  
The lamina propria and epithelium are the main distribution site for effector cells in the 
intestinal immune system and their compartments are very distinct. The lamina propria is rich in 
B cells, T cells and great amount of innate immune cells such as DCs, macrophages, eosinophils 
and mast cells. The epithelium contains T cells primarily. In summary, lamina propria and 
epithelium contain the largest population of innate immune cells in the body[1]. 
1.1.2.2 Role of intestine in food allergy 
As mentioned above, the varieties of intestinal compartments made intestine a good 
barrier for nutrients absorption and exclude the unwanted components, such as pathogens or 
allergen. Under normal conditions, after the consumption of nutrients, most of food proteins 
are hydrolyzed under the action of gastric, pancreatic and small intestinal brush border 
proteases such as pepsin, trypsin and chymotrypsin, to a mixture of free amino acids, di and tri-
peptides and other proteolysis products for absorption[3]. There are still around 10% of the 
proteins that escape from proteolysis crossing intestinal barrier intact[3]. Husby et al. detected 
intact ovalbumin in human blood after egg white consumption by using a combination of HPLC 
and ELISA[4]. It is believed that those intact proteins and peptides may contain intact epitopes 
to be recognized by antigen presenting cells and induce sensitization or to elicit an allergic 
reaction. It is shown that 40% of the hydrolyzed protein have an 1100 Da molecular weight, 
which is still big enough to be recognized by MHC-II molecules (minimum length: 18-20 amino 
acids)[5]. Besides, 2% of intact proteins are estimated to reach mesenteric lymph nodes and 
portal circulation under normal conditions[6]. 
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How do these non-fully hydrolyzed proteins absorbed as intact? Firstly, besides not fully 
hydrolysis through proteolysis, other trans-cellular pathway can also enhance antigen uptake by 
enterocytes and absorbed as intact. One of the believed mechanisms is the IgE coating theory. 
The luminal antigen-specific IgE forms a complex with antigen which are transported by CD23 
receptor, which are overexpressed in the sensitized persons, trans-cellularly without lysosomal 
degradation across the intestinal membrane[7].  
It is reported that antigens are secreted into exosomes after uptake with or without 
lysosomal degradation[8]. Thereafter, the antigen-containing exosomes cross basolateral 
membrane pore and enter circulation to reach MHC-II molecules to present the antigen to T 
cells[9, 10]. Inflammatory conditions may enhance these exosomes from intestinal epithelial 
cells[9]. However, the role of these exosomes remains debatable. Besides, IgA and IgG are 
involved in enterocytic antigen transport as well. The Polymeric IgA reach the intestinal lumen 
by polymeric IgA receptors[11]. However, different from IgE, IgA binds antigen to prevent their 
absorption and can lead to secretion back to intestinal lumen[3]. Therefore, antigen-specific IgA 
is considered to play a protective role in sensitization and allergic reactions. Polymeric IgG is 
secreted to intestinal lumen by Fc receptors and binds antigen as a complex as well. It is 
believed absorption of IgG-antigen complex in the neonate seems to be protective from 
sensitization, yet the role in adults remains unclear[12]. M cells, the specialized epithelial cells of 
Peyer’s patches, have been shown to transport proteins, bacteria, viruses and other particles of 
size smaller than 1µm[13]. It is suggested that M cells transport proteins or antigens via a basal 
pocket which is rich in B and T cells, macrophages and dendritic cells[14, 15]. The exact function 
of the pockets remain unclear but it is assumed that the pockets may shorten the intracellular 
distance before antigens being seen by antigen presenting cells (APC), which then migrate to 
antigen-specific lymphocytes to induce T cell proliferation[3]. M cells have been confirmed to 
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transport both soluble and insoluble peptides. Sensitization or tolerance induction most likely 
depends on the particle sizes[16, 17]. Mast cells, DCs, macrophages and goblet cells are also 
thought to influence protein transport in the intestine yet the mechanisms remain 
controversial[3]. Taken these findings together, intestine is a significant organ to study the 
initiation of food allergy and has significant potential to works as an important therapeutic 
target for food allergy prevention and treatment. 
1.1.3 Role of intestine in cholesterol homeostasis 
Whole body cholesterol homeostasis is highly regulated by a balance of sterol uptake, 
absorption, de novo synthesis, fecal losses and export of intestinal lipoproteins, principally 
chylomicrons[18]. Intestine contributes significantly to sterol uptake, absorption and reverse 
cholesterol transport process. 
Both dietary and biliary cholesterol are found absorbed from intestinal lumen in the 
proximal jejunum of small intestine. This process has been considered solely passive despite the 
fact that cholesterol is absorbed in a high efficiency yet the structurally similar plant sterols are 
not. The mechanisms of the interaction between sterols and intestinal brush-border membrane 
transporters still remain controversial, but it is proved that the key step of this process is to 
interact with Niemann-Pick C1 like 1 (NPC1L1) by the discovery of a powerful cholesterol 
absorption inhibitor, ezetimibe, a drug that inhibits intestinal sterol absorption by binding to the 
NPC1L1 transporter and blocking its internalization with sterol via clathrin-coated vesicles[19]. 
NPC1L1 is expressed at the brush border membrane of intestine and NPC1L1 deficient mice 
showed around 70% reduction in cholesterol absorption[19]. ABCG5/G8 are heterodimers 
cholesterol transporter located at the canalicular membrane of hepatocytes and the brush 
border of enterocytes. In humans, mutations in genes encoding ABCG5 or ABCG8 were shown to 
cause sitosterolemia (STSL) characterized by accumulation of plant sterols in blood and tissues 
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due to the increased intestinal sterols absorption and decreased biliary removal[20]. G5 and/or 
G8 in mice were confirmed to upregulate plant sterol absorption[21] yet the effect on 
cholesterol absorption efficiency are limited[22]. In contrast, overexpression of G5G8 in mice 
leads to a dramatically reduced cholesterol absorption efficiency under pharmacological 
induction[23], indicating G5G8 manipulate cholesterol absorption under certain conditions. In 
the small intestine, SR-B1 localized both apical and basolateral phases of enterocytes. It was 
reported that SR-B1 deficiency only leads to a slightly increase in cholesterol absorption and 
decrease in fecal neutral sterol loss[24]. Similary, overexpression of SR-B1 did lead to increased 
cholesterol absorption, suggesting a possible role of SR-B1 in intestinal cholesterol 
absorption[25]. After uptake by enterocytes, cholesterol is esterified to cholesterol ester by 
ACAT2 at the endoplasmic reticulum (ER). ACAT-2 deficiency in mice would reduce cholesterol 
absorption upon high fat, high cholesterol Western diet feeding yet no clear reduction of 
cholesterol absorption was found in mice fed with chow diet[26]. Other proteins like 
microsomal triglyceride transfer protein (MTTP) and apolipoprotein B (apoB) are crucial in 
chylomicron formation, a critical process for cholesterol absorption. Mutations in MTTP gene 
leads to abetalipoproteinemia characterized by extremely low plasma cholesterol and TG levels 
and absence of apo-B-containing particles[27]. 
As described above, intestine plays a significant role in cholesterol homeostasis as a 
cholesterol absorbing tissue. It is recently revealed that intestine also acts as a cholesterol 
secretion tissue in Reverse Cholesterol Transport (RCT) process. Details will be discussed in the 
paragraph 1.3.4. In summary, besides an absorptive tissue, intestine has significant potential as 
a therapeutic target for maintaining cholesterol homeostasis in the whole body. 
1.2 Peanut Allergy and Dietary Fats  
1.2.1 Peanut allergy 
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Food allergy is thought to cause more than 50,000 cases anaphylaxis and estimated 100 
deaths annually in the U.S. The foods that induce allergy can be divided into two groups briefly: 
1) the foods that commonly cause food allergy in infants and young children but rarely cause 
food allergy in adults and rarely cause death, such as milk and eggs. 2) the foods that cause food 
allergy in both children and adults and very likely to cause severe shock and death, such as fish, 
shellfish, nuts and peanuts[28]. Of the second category, peanuts are inexpensive and broadly 
consumed in unmodified form and the components of many food products, causing the largest 
population of peanut allergy with severe anaphylaxis and death in U.S[29]. 
1.2.1.1 The prevalence and pathogenesis of peanut allergy 
Several studies have evaluated peanut allergy prevalence in the U.S. and Canada and 
determined if it is changing by time. In one study, 1.4% of subjects were reported peanut or tree 
nuts allergy by random telephone survey [30]. This percentage in children (less than 18 years) 
increased from 0.6% in 1997 to 1.2% in 2002 and 2.1% in 2007. Yet the percentage remains 
unchanged in adults [31]. Consistent with the increased peanut allergy prevalence in children, 
the data of evaluating hospitalization rates for peanut induced anaphylaxis in New York State 
showed a 4-fold increase from 1990 to 2006 for young subjects younger than 20 years[31]. 
Another study, however, reported that only 22% of the children (8 years) who were diagnosed 
to be peanut sensitized based on skin prick testing or plasma IgE measurements had positive 
response to oral peanut challenge[32], indicating that not all people who have “peanut allergy” 
would actually develop anaphylaxis responses following peanut consumption. Even so, some 
studies showed that children with asthma and peanut allergy had 2.32-fold more 
hospitalizations for asthma than asthmatic children without peanut allergy[33]. Furthermore, a 
survey found that the incidence of peanut allergy in sibling of patients with peanut allergy is 6-7 
fold higher than the siblings of children without peanut allergy[34]. 
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A British study evaluated the relationship between peanut exposure and peanut allergy 
development. In the study, the prevalence of peanut allergy of Jewish children in the UK are 
found 10% less than the Jewish children in Israel [35]. The hypothesis from this study is that the 
early consumption of peanut product (bamba, food made from peanut butter and puffed corn) 
by Israeli infants may reduce the chance to develop peanut allergy because the infants in the UK 
avoid peanut products. However, non-oral exposure to peanuts, especially peanut butter, is 
found related to increased risk of peanut sensitization[36]. These studies indicate but not 
proved that consumption of peanut products at early life would reduce the risk of peanut allergy 
development. More animal experiments and clinical trial in infants needed to be initiated to 
provide more evidences to test the hypothesis. 
Peanut allergy shares the similar induction mechanism as other food allergy which can 
be broadly divided into IgE mediated or non-IgE-mediated reactions. In IgE-mediated food 
allergy, exposure to glycoproteins in food would cause a series reactions among antigen 
presenting cells (APC), T cells, B cells, and production of IgE, which resides on mast cells and 
basophils. This phase is named “sensitization” (Figure 2). The same glycoprotein exposed to the 
sensitized subjects the second time would bind the IgE residing on mast cells and basophils 
which induces the activation and degranulation of these cells. Activated mast cells and basophils 
release histamine and other inflammatory chemical mediators that cause systemic reactions 
such as mucous secretion, smooth muscle contraction and vasodilatation. These effects result in 
symptoms like rhinorrhea, itching, dyspnea and anaphylaxis (Figure 2)[37]. Non-IgE mediated 
food allergy is more common. Activation and recruitment of lymphocytes and eosinophils are 
the cause of these diseases and symptoms. 
Studies based on mouse model showed that IgE, mast cells and IL-13 are required for 
peanut allergy development[38]. Unlike requirements of IgE and mast cells that were  
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Figure 1.2 Sensitization and allergic reaction[37].  
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demonstrated in food allergy models requirement for IL-13 were recently shown to effect on 
vascular and epithelial cell permeability and smooth muscle contractility, the critical factors in 
food allergy induction[38]. A separate study reveal the complement is activated by aqueous 
extracts of peanuts and tree nuts but not milk or eggs in both mouse and human plasma[39]. In 
addition, peanut extract would exacerbate the severity of IgE-mediated anaphylaxis in mice 
through complement activation mechanism, indicating the complement by components from 
peanuts contributes to anaphylaxis induction significantly [39]. 
1.2.1.2 Peanut allergens 
Allergens are defined by the binding ability to plasma IgE from allergic individuals and 
the activation ability of mast cells and/or basophils that have been sensitized with serum rich in 
IgE[28]. Chung and Champagne reported that roasted peanuts have higher binding ability to IgE 
than raw peanuts, suggesting their potency in allergy induction[40]. Based on these criteria, 11 
peanut allergens have been determined (Table 1). 
Among the 11 allergens, Arah 2 and 6 are considered to be more potent in peanut 
allergy development than others although the other allergen also bind IgE from majority of 
peanut allergic subjects[41]. To determine the epitopes of Arah 2, some studies have 
demonstrated that most IgE from peanut-allergic patients’ serum binds to the conformational 
epitopes generated by native polypeptide folding of the allergen, rather than the linear epitopes 
generated by consecutive amino acids independent of polypeptides folding. However, it is still 
unclear how this finding explain the previous evidence that the patients with high concentration 
of serum IgE specific for linear epitopes of peanut allergen usually had the worst allergic 
symptom of allergy[42]. 
Some studies aimed at modifying peanut allergenicity by decreasing the levels of Arah 2 
and 6. These studies suggested the feasibility of the approach, yet the hypothesis that peanuts  
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Table 1 Characteristics of Peanut Allergens [43] 
Allergen Molecular  Molecular Mass  Characteristics 
 
Ara h 1 63 k‐Da Member of vicilin family of 
seed storage proteins, a 7S 
globulin 
 
Ara h 2 17–19 k‐Da Member of conglutin family 
of seed storage proteins, a 2S 
albumin 
Ara h 3 14–45 k‐Da processed from 
64 k‐Da protein 
Member of glycinin family of 
seed storage proteins; 
heteromultimeric protein 
formed from differently 
proteoltically 
processed products of the 
same gene, an 11S globulin 
 
Ara h 4 37 k‐Da Isoform of Ara h 3 
Ara h 5 15 k‐Da Member of 
profilin family of 
G‐actin‐binding proteins 
 
Ara h 6 15 k‐Da Member of conglutin family 
of seed storage proteins, a 2S 
albumin 
Ara h 7 17 k‐Da Member of conglutin 
family of seed storage 
proteins, a 2S albumin 
 
Ara h 8 16 k‐Da Homologous to major birch 
pollen allergen, Bet v 1 and 
other pathogenesis‐related 
proteins 
Ara h 9 9.8 k‐Da Lipid transfer protein 
 
Ara h 10 16 k‐Da Oleosin seed storage protein 
 
Ara h 11 14 k‐Da Oleosin seed storage protein 
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depleted of Arah 2 and 6 have less allergenicity than conventional peanuts was not tested[44]. 
One concern about this approach is that populations with different geographical distributions or 
ethnics are prominently sensitive to different allergens. For example, one study demonstrated 
that Arah 9, an allergen that is relative insignificant to induce allergy in U.S., is a very potent 
allergen for peanut-allergic patients from Mediterranean area than Arah 1, 2 and 3[45]. 
Secondly, like mentioned in 1.2.1.1, since peanut allergy is comprised of sensitization and 
anaphylaxis phases, although Arah 2 and 6 have the highest affinities to IgE in peanut-allergic 
patients’ serum (for the anaphylaxis phase), other allergens play important roles in sensitization 
phase. With the regard, crude peanut extract is much more allergenic than any of the purified 
major allergens in animal studies [46]. 
It is worth noting that despite the less potency of binding IgE from allergic patients, 
other allergens such as Arah 5, 8 and 9 are types of panallergens, which are responsible for 
allergic cross-reactivities across a broad range of unrelated plants. The cross-reactivities are 
always associated with birch and grass pollen or involved in “nsLTP-syndrome)[47]. 
1.2.1.3 Current therapies for peanut allergy 
Currently, the only therapy for peanut allergy is to strictly avoid peanuts and their 
related products. Allergens from peanut would cause severe anaphylaxis reactions even the 
patients only had very mild symptoms before [48]. Therefore, besides strict avoidance, the main 
managements of peanut allergy focus on are to closely observe the early symptoms due to 
accidental ingestions and to self-administer epinephrine [49]. However, one study reported that 
these approaches negatively affect patients’ life qualities [50]. Hence, therapeutic approaches 
that modify the immune responses to peanut allergens are needed to protect patients from 
accidental peanut exposure. Such novel immunotherapeutics are generally classified into 
allergen-specific and allergen-nonspecific. 
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Allergen-specific immunotherapy is based on induction of immune tolerance to peanut 
in IgE-mediated allergic patients by approach of administering patients with progressively higher 
doses of potent allergen over a relative long period such as weeks or months to induce clinical 
desensitization. ‘Clinical desensitization’ refers to the threshold dose of the potent allergen 
required to induce allergic response. Immune tolerance is defined as to induce a permanent non 
response to the offending allergen associated with the ability of the allergen ingestion and no 
more ongoing therapy[51]. Approaches of administering offending allergens including 
subcutaneous injections, and oral, sublingual or epicutaneous applications. Subcutaneous 
immunotherapy (SIT) is to applicate food allergen through subcutaneous injection. This therapy 
is usually associated with high risk of severe allergic reactions. Preliminary studies on this 
therapy showed a reduced skin-prick test (SPT) reactivity and increased tolerance to ingested 
peanut in the patients with oral challenges[52]. However, systemic reactions occurred in the 
following therapy and the authors concluded that modified peanut extracts were needed for 
such treatments [52]. Oral Immunotherapy treatments (OIT) have made progress toward safer 
and more efficient treatment for peanut allergy. Some clinical studies suggest that OIT is 
effective on clinical desensitization and oral tolerance induction among more than 50% children 
by raising threshold dose (at least 10 peanuts) of allergic reaction, which showed the clinical 
efficacy for desensitization during accidental peanuts ingestion[53, 54]. However, other aspects 
like mechanisms of action, dosing regimens and short-phase and long-phase effects still need to 
be established[55, 56]. Sublingual Immunotherapy (SLIT) is effective for tolerance induction on 
respiratory allergies [57]. Peanut EPIT is prolonged and repeated administration low dose of 
peanut allergens through epicutaneous injection. Similar to subcutaneous immunotherapy, 
preclinical studies showed that EPIT also induce desensitization and tolerance to the subsequent 
oral peanut challenge [58-60]. In a recent study in France, it was shown that EPIT was to reach a 
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cumulative threshold dose of peanut allergens 10 times higher than the beginning of the study 
after 18 months treatment, and 40% of the patients were desensitized to the threshold 
doses[61]. Therefore, it is indicated that EPIT is safe and effective in desensitizing allergic 
children to peanut. Immunotherapy with hypoallergenic mutants combined with bacteria 
Adjuvant were shown safe and effective in mice but it is not applicable in humans due to the 
adverse reactions[51]. 
Allergen non-specific therapies include silencing allergen-encoding foods in transgenic 
plants, anti-IgE therapy and DNA vaccines. Since the techniques of these therapies are either not 
mature enough or have some unsafe factors, most of them need more researches to 
establish[51]. 
An efficient therapy might be a good combination of both allergen-specific and allergen-
non-specific applications. Therefore, the current most safe and efficient therapy still rests in 
prevention. 
1.2.2 Dietary Fatty Acids 
1.2.2.1 Category of Dietary Triglycerides 
Dietary Triglycerides (TGs) are indispensable components in our daily diets, they are the 
main constituents of vegetable oil and animal fats. A TG is composed of three fatty acids (FAs) 
esterified to a glycerol molecule in one of the three distinct bonding positions. The combination 
of differences in FA types as well as the positions where they attached to glycerol molecule give 
rise to the huge heterogeneity of TGs one can ever think of. FAs are the major and functional 
unites of TGs and make up approximately 90% of total TG mass for most dietary oils we 
consumed. Three FAs of TGs are generally linear hydrocarbon chains consists with even number 
of carbons atoms ranging from 4 to 26. FAs that have less than 8 carbons are recognized as 
short-chain FAs (SCFA), 8 to 14 carbons as medium-chain FAs (MCFA) and long-chain FAs (LCFA) 
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for those that have 16 or more carbons. The amount of all these FAs varies depend on the 
source of oil but they all exist in human diets.  
In addition to differences in the length of carbons chain, depending on whether or not a 
FA contains double bonds, FAs can be categorized into two types: saturated FAs and 
unsaturated FAs, unsaturated FAs can be further sub-categorized into monounsaturated FAs 
(MUFAs, contains a single double bond) and polyunsaturated FAs (PUFAs, contains two or more 
double bonds). Two systems have be used to identifying the position of double bonds along the 
hydrocarbon chain entail carbon counting from either end of the FA molecule. The less 
commonly used “Δ” system starts the carbon counting from the carboxyl end of the fatty acyl 
chain, whereas the more commonly used “ω or n” system identification of the position of the 
first carbon of a double bond relative to the methyl end. For example a ω-3 (n-3) FA, indicates 
that the first double bond is positioned between the third and fourth carbon atoms from the 
methyl end. In order for a FA to have a single double bond, it must be at least 12 carbon atoms 
in length. For PUFAs, each subsequent double bond almost invariably occurs there carbon atoms 
further along the chain. Thus the number of double bonds within a given FA is restricted 
depending on its length. And so dietary FAs can contain multiple double bonds up to 6.  
Our body have the machinery to insert double bonds at the n-9 position or higher during 
FAs de novo synthesis but not at any position closer to the methyl end. Thus, FAs with double 
bonds at the n-3 and n-6 positions can’t be constructed by ourselves but they are essential to 
normal growth in youth and those FAs are considered essential. Essential fatty acids (EFAs) 
therefor must be obtained from plants and other organisms that possess the machinery for their 
synthesis. For instance, dietary sources like walnuts, salmon and soybeans are rich in n-3 FAs, 
poultry meat, eggs and avocado are rich in n-6 FAs. Regardless of their essentiality, whether or 
not consume EFAs have positive health effects on against chronic diseases such as 
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cardiovascular diseases (CVDs) and cancer are still under debate. Indeed, some research 
suggested that excessive levels of certain n-6 FAs relative to n-3 FAs may increase the risk of 
developing a number of diseases,[62] thus an appropriate ratio of n-6 to n-3 FAs need to be 
considered when consuming those EFAs, preferentially 1:1 vs. average 15:1 in typical western 
diet.[63]  
In nature, double bonds in USFAs are present in the cis configuration, in which the 
carbon chain extend at the same side of the double bond and thus creates a kink at the site of 
double bond resulted in a bent hydrocarbon chain; however, trans FAs do present in some food 
which are a result of hydrogenation of vegetable oil, a process to increase the viscosity of oil and 
acquire more desirable physical properties, higher melting temperature for example.[64] As 
appose to cis configuration, carbon chain in trans fat extend from the opposite side of the 
double bond and result in a straighter molecular much like saturated FAs. Although trans fat is 
edible and can be metabolized, intake of trans fat perturbs the ability of our body to metabolize 
essential fatty acids result in changes in fatty acid composition in aorta, moreover, consumption 
of trans fat are associated with increased LDL, decreased HDL and thereby increases the risk of 
coronary heart disease.[65] On 16 June 2015, the FDA finalized its determination that trans fats 
are not generally recognized as safe since its predetermination in 2013, and set a three year 
time limit for their removal from all processed foods. 
1.2.2.2 TG metabolism 
The digestion of dietary lipids begins in the oral cavity via the action of an enzyme 
known as lingual lipase. With the process of salivation and mastication, lingual lipase released 
form the serous glands hydrolysis of free FAs from TGs. This enzyme cleaves at the sn-3 position 
and preferentially hydrolyzing shorter-chain FAs in foods. Continuous digestion happens in 
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stomach, where gastric lipase promotes further hydrolysis of SCFAs from TGs. However the 
major site for dietary lipids digestion is in intestine. Intestinal digestion of TGs requires bile salts 
(BSs) and pancreatic lipase. With the help of colipase, also a pancreatic protein, pancreatic 
lipase adheres to the surface of TG droplet and acts to hydrolyze ester bonds at sn-1 and sn-3 
position of the glycerol moiety. FAs at the sn-2 position however are resistant to hydrolysis by 
lipase. Hydrolysis products, monoglycerides (MGs) and free FAs are then incorporated in to BSs 
containing micelle with the help of phospholipids (PLs), cholesterol (CH) and colipase for their 
transport and subsequent cellular uptake.  
The absorption of lipid hydrolysis products occur in large part through passive diffusion. 
First stage of absorption featured with the penetration of micelles across the unstirred water 
layer adjacent to the brush border surface of intestine mucosal cells. Due to its smaller size and 
the amphipathic nature, micelles but not larger lipid droplet are readily to approach and enter 
the water layer upon formation and continue to shuttle hydrolysis products through in a 
concentration-dependent fashion. This process primarily count on the lower cellular 
concentration of lipid hydrolysis products in the enterocyte, this is achieved by the rapid re-
esterification of intracellular digestion products to form TGs by enzymes of the endoplasmic 
reticulum (ER). Also the intestinal FA binding proteins (FABPs) are involved to assist FAs 
absorption. Besides the process described above, FAs with chain lengths less than 12 carbon 
atoms are also readily absorbed passively by the gastric mucosal boundary and are taken up by 
the portal vein. [66] The efficiency of fat absorption is likely independent of the amount 
consumed but may influenced by the qualitative nature of dietary fat. In general, efficiency 
increases with the degree of FA unsaturation but decreases as FA chain length increases. In 
addition, the position or order of FAs attached to TGs also matters. [67]  
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After absorption, short- and medium- chain fatty acids directly enter the blood via 
intestine capillaries and travel through the portal vein just as other nutrients. But long-chain 
fatty acids are absorption into fatty walls of the intestine villi and reassembled again into 
triglycerides, which coated with cholesterol and apolipoprotein are processed into chylomicrons. 
The chylomicrons are released into lymphatic circulation and transported to thoracic duct up to 
a location near the heart. The thoracic duct empties the chylomicrons into the bloodstream via 
left subclavian vein, where chylomicrons can transport triglycerides to tissues for energy 
metabolism or storage. 
1.2.2.3 Disease related to dyslipidemia 
It is conceivable that any defect happened along the process of lipid digestion 
absorption or transportation might cause disorders in lipid metabolism in our body. For example 
celiac sprue, a common disorder of small intestine that results in lipid malabsorption is 
characterized by lesions of the small intestinal mucosa associated with gluten toxicity.[68] 
Deficiency of pancreatic enzymes necessary for lipid digestion resulted in accumulation of large 
amount of undigested fat in stools is another common disorder which can be treated by 
prescribing a low-fat diet or by supplementation of pancreatic enzymes with meals.[69] Bile salt 
deficiency as consequences of liver disease or gallstone disease results in poor micellar 
solubilization of lipid digestion products and thus insufficient delivery of lipid molecules to the 
small intestinal epithelial cells and accumulation of mainly lipid digestion products in the stool. 
Since dietary fat is the exogenous source of body lipids, malabsorption of fat can lead to 
hypolipidemia, a form of dyslipidemia that is defined by abnormally lowered levels of any or 
all lipids and/or lipoproteins in the blood. Hypolipidemia is relatively uncommon and might be 
asymptomatic in general, however, studies reported close association of this type of 
dyslipidemia with disorders such as anemia, hyperthyroidism and inflammation.[70] In contrast 
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to hypolipidemia, hyperlipidemia is one of the most common form of dyslipidemia involves 
abnormally elevated levels of any or all lipids and /or lipoproteins in the blood. Hyperlipidemia 
can be divided into primary and secondary subtypes.[71] Primary hyperlipidemia is mainly due 
to genetic causes, for instance, deficiency in lipoprotein lipase, enzymes that hydrolyzis TGs in 
lipoproteins, resulting in elevated chylomicrons, the particles that transfer fatty acids from 
the digestive tract to liver. Mutations affect low density lipoprotein receptor (LDLr) or 
apolipoprotein B (ApoB, primary apolipoprotein of lipid reach particles such as chylomicrons) 
result in decreased clearance and elevated blood lipid. Secondary hyperlipidemia or acquired 
hyperlipidemia are usually consequences of underlying conditions such as diabetes, using of 
drug, hypothyroidism and so on. This type of hyperlipidemia often mimic the primary form and 
may have very similar consequences. The fact that hyperlipidemia is such a big health concern is 
that it is very common in population and it is a strong risk factor for cardiovascular diseases due 
to its influences on atherosclerosis. However hyperlipidemia as a CVD risk factor is modifiable, 
thus dietary modification is often the initial approach for treatment of certain types of 
hyperlipidemia.     
1.2.2.4 Pharmacutical effect of TG on intestinal epithelial cells  
The intestine is the critical site for dietary lipid digestion and absorption. Hydrolyzed 
lipid products were uptake by enterocytes through passive diffusion or facilitated by 
transporters. Enterocytes have the capability of eliminate free fatty acid toxicity in cytosol by 
quickly synthesize TGs and for its secretion later in the form of chylomicron. However, to what 
extent this process is controlled have not been fully explored. It is believed that intestine is not 
just an absorption organ, it is also able to modulate lipoprotein production in response to 
various stimuli and signaling pathways to control the amount of lipids that enter the body.[72] 
Recent studies suggested intestine as an insulin sensitive organ, and dysregulation of insulin 
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signaling in intestine resulted in enhance lipogenesis and lipoprotein synthesis, which might be 
key mechanism for atherogenic dyslipidemia in patients with metabolic syndrome.[73] Beside as 
a digestive organ, the intestine also harbors an ecosystem along its length, it is the first barrier 
for bacteria and antigen infiltration and important party of host defense of our body. The excess 
amount of dietary lipids present in the intestine lumen can very well be served as an external 
stimuli that influence the physiology and functionality of the intestine. Perfusion of emulsified 
lipids but not casein or glucose resulted in dose-dependent disruption of the epithelial 
monolayer, the damage can be reversed acutely after stimuli withdraw followed by saline 
perfusion.[74] This suggest that the intestinal epithelium is constantly injured and restitutes 
during the normal digestion and absorption of a meal. However this balanced process can 
sometime be disrupted and lead to unfavorable consequences. For instance, excessive amount 
of fat in complex high fat (HF) diet induces low grade endotoxiemia in parallel with increased 
intestinal goblet cell number in experimental mice model.[75] In colonic adenoma rat model, 
chronic HF feeding promote formation of colonic adenoma through inflammation associated 
with increased circulating TNF-α.[76] Interestingly, the types of TGs present in diet also matters. 
Diet reach in MCT have been indicated to suppress intestinal mucosa atrophy in septic rats,[77] 
decrease gut injuries and mortality in rats exposed to LPS.[78] MCT can also blunt ethanol effect 
to increase gut permeability in experimental mice model.[79] Besides the matter of chain length, 
diet reach in saturated fat is linked to various chronic disease, including inflammatory bow 
diseases as well as CVDs, which may attributed to the ability of saturated fat to induce ER stress 
and macrophage activation result in foam cell formation and tissue inflammation.[80] 
1.2.2.5 Dietary fatty acids and allergy 
Currently, most of the studies on the relationship between dietary fatty acids and 
allergy focus on the effect of polyunsaturated fatty acids. Fish oil supplementation during 
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pregnancy and lactation have demonstrated the benefits of omega-3 PUFAs to the offspring 
which is associated with immunologic changes[81-83]. These studies indicated the clinical 
effects of early fish oil provision including reduced sensitization to food allergens and reduced 
severity and prevalence of atopic dermatitis in the first year. In Australia, a study on around 700 
infants proved that high-dose (900mg/day) omega-3 PUFAs intake during pregnancy did not 
reduce the IgE associated food allergy in the first 12 months of life, although omega-3 PUFAs 
supplementation lowered egg sensitization[84]. Other studies showed that fish oil 
supplementation during infancy or childhood resulted in higher omega-3 PUFAs in infants and 
children and may be associated with immunologic changes in the blood[85-87]. However, the 
clinical implication of these studies are still not clear. 
Western diet is consisted of relative balanced ratio of omega-3 and omega-6 PUFAs that 
was predominantly rich in omega-6 PUFAs, which may suggest a possible cause of high 
prevalence of allergic diseases in the developed countries[88]. Predisposition to allergy disease 
is due to insufficiently balanced types of T help cell, type 1 and type 2 (Th1 and Th2) during fetal 
life[89]. High levels of dietary omega-6 PUFAs has been shown to promote Th2 differentiation of 
immune system during ontogeny and development[88]. In contrast, omega-3 PUFAs may shift T 
helper cell balance by inhibiting production of IL-13, a cytokine related to the induction of 
allergic disease through inducing IgE synthesis in B cells and Th2 differentiation in T cells[90]. 
Therefore, it is very likely that diets high in omega-3 PUFAs may regulate development of IgE 
mediated allergy diseases and the related immune responses[84]. 
There are very few studies focus on effects of other types of FA on allergy disease such 
as saturated FAs, long-chain vs. medium chain FAs or trans-FAs. Since the other types of fatty 
acids comprised the majorities of dietary fats or very hard to avoid, it may be meaningful and 
more relevant to determine the roles of other fatty acids on food allergy. 
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1.3 Reverse Cholesterol Transport 
1.3.1 Prevalence, pathogenesis and therapeutic strategies of atherosclerosis and the related 
heart disease 
In 2011, the mortality of CVD in the U.S. was 229.6 per 100,000 people, indicating more 
than 2150 Americans die of CVD each day and 1 death every 40 seconds on average[91]. Among 
these people, about 155,000 Americans who died of CVD were less than 65 years old. The 
majority of the lethal CVDs are associated with and caused by atherosclerosis[91](Figure 3), a 
disease of vascular intima, in which the whole vascular system is involved from aorta to 
coronary arteries and is characterized by intimal plaque[92]. 
Atherosclerosis is processed from lesion formation and luminal narrowing of arteries, 
which give rise to other diseases like cerebrovascular disease coronary artery disease (CAD). The 
plaque rupture and thrombosis are the signs of acute coronary syndrome (ACS), myocardial 
infection or stroke. The pathology is characterized by a chronic inflammatory process of a 
certain site of arterial wall such as branch points, which affect the normal blood flow[93]. The 
inflammation initiates from endothelial structural alteration and dysfunction which allow 
accumulation of low density lipoprotein (LDL) in endothelial cells. High levels of apolipoprotein 
B100 (apoB100)-containing LDL-derived cholesterol is positively correlated with atherosclerosis 
and cardiovascular disease[94]. Oxidized LDL (oxLDL) and lipids induce the adhesion molecules 
expression and chemokines secretions in endothelial cells, which initiate intimal immune cells 
infiltration together with deposition of platelet-derived chemokines[95]. Early lesions comprised 
of T cells and monocyte-derived macrophage-like lipid loading foam cells. On the site, apoptotic 
cells, debris and cholesterol crystals accumulation form the necrotic core. Fibroatheromatous 
plaques are comprised of collagen and smooth muscle cells (SMCs), which will be replaced by 
macrophages in the thinning inflamed area and induce rupture. The middle area are rich in 
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Figure 1.3. Percentage breakdown of deaths attributable to cardiovascular disease (United 
States: 2011). [91] 
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infiltrated T cells and mast cells that lead to adventitial inflammation of advanced plaques by 
producing proinflammaory mediators and enzymes[96].  
The healthcare systems are heavily burdened by the high incidence of atherosclerosis-
related cardiovascular disease. Current available therapeutics on patients largely focus on 
hypertension, hyperlipidemia alleviation and enhancing reverse cholesterol transport (RCT) from 
lipid-laden macrophages[95]. To achieve this purpose, the most established approach includes 
statin treatment, which yields a pronounced risk reduction due to the effect on LDL-derived 
cholesterol lowering. Also, statins exerts anti-inflammatory functions, improve endothelial 
functions and plaque lipids reductions, which limits and stabilize atherosclerotic plaques[97]. 
High dose of atorvastatin decreased high-sensitivity C-reactive protein (hs-CRP) levels in serum 
and regression of atheromas by lowering LDLc aggressively[98]. Aggressive statin therapy also 
decreased the primary endpoints such as myocardial infarction, benefiting the patients with 
LDLc lowering and CRP both[94]. However, according to the most recent statistics report of 
Management of Atherosclerotic Cardiovascular Disease Risk, the CVD-associated mortality and 
morbidity were not reduced prominently with LDLc lowering with statin therapy[99]. Besides 
LDLc lowering, HDLc elevating therapy had become the promising therapeutic approach due to 
the role of more relevant predictor of HDLc than LDLc for CVD in a great amount population 
studies[100] and their significant roles in RCT by using Niacin or CETP inhibitor. Cholesteryl ester 
transfer protein (CETP) is a protein in plasma that exchange of cholesteryl ester in HDL for 
triglyceride in larger density lipoproteins like LDL or VLDL. Therefore, CETP is always considered 
potential atherogenic[101-103] and CETP inhibitor treatment was found to reduce 
atherosclerosis prominently in animal study[104]. However, besides aldosterone-related 
adverse effects[105], many clinical trials of niacin[106] and cholesteryl ester transfer protein 
(CETP) inhibitor Dalcetrapic[107] have shown the independence of high HDLc levels to the risk of 
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CVD in human beings. The 2013 American College of Cardiology ad American Heart Association 
cholesterol guidelines made no specific recommendation for targeting HDL-C in therapy of 
prevention or treatment of atherosclerosis associated CVD due to the lack of convincing 
data[108]. It was showed that artificial HDL-like apolipoprotein A1 complexes (apoA1-Milano) is 
promising in CVD regression[109] by their abilities in binding oxidized lipids and anti-
inflammatory functions[110]. Likewise, these emerging therapeutic strategies ongoing focus on 
the mimic the structure of natural HDL or replicate their functions such as RCT, vasodilation, 
anti-inflammation, and inhibition of platelet aggregation although they still confront with 
translational challenges[111]. 
Although many studies and clinical trials failed to confirm the protective role and the 
positive correlation of HDLc to atherosclerosis associated CVD, it is still well accepted that 
enhancing process of RCT can prevent or may regress the disease. 
1.3.2 Reverse Cholesterol Transport (RCT) 
Cholesterol can leave the body as neutral sterols (original cholesterol and its 
metabolized products by intestinal bacteria) or bile acids. RCT is to classically define the process 
of cholesterol metabolism from cholesterol efflux from peripheral tissues or macrophages to 
final excretion into feces either as neutral sterol or bile acids[112-114]. 
Hepatobiliary RCT has been considered the main pathway for cholesterol elimination for 
decades. Liver plays a significant role in cholesterol metabolism and cholesterol homeostasis. In 
the hepatocytes, cholesterol from source of diet or synthesis within liver or intestine is 
processed into apoB-containing lipoproteins and secreted back to the circulation basolaterally as 
the supply cholesterol to peripheral tissues[113]. Under certain circumstances, the chemically 
modified lipoproteins are taken up by macrophages which then result in foam cell 
formation[115] which are atherogenic as mentioned above. Cholesterol can be effluxed from 
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macrophages as free cholesterol via either ATP binding cassette transporter A1 (ABCA1) with 
lipidated apoA-I or ABCG1 with more mature HDL as acceptors[114, 116]. Scavenger receptor 
class B type 1(SR-BI) and aqueous diffusion may be responsible for other cholesterol efflux 
capacity[114, 116]. After uptake by HDL, cholesterol is esterified by lecithin-cholesterol 
acyltransferase (LCAT) thus sparing some space on the surface of HDL for additional free 
cholesterol[117]. Cholesterol is transported back to the liver through plasma compartments. 
Hepatocytes uptake HDL selectively by SR-B1 or via a not fully-understand pathway[112]. 
However, some studies showed that mice with extremely low circulating levels of HDL (apoA-I or 
ABCA1 deficient mice) have normal biliary and fecal cholesterol excretion, indicating that the 
levels of circulating HDL cholesterol contribute little to the amount of cholesterol leaving body 
via bile or feces[118-121]. After uptake by hepatocytes, cholesterol is de-esterified and secreted 
into bile via ABCG5/G8[22], a heterodimer transporter expressed in liver and intestine in the 
form of free cholesterol, or through ABCB11, a bile acids transporter in the form of bile 
acids[122]. Recent studies showed that in mice with altered expression of Niemann-Pick C2 
(NPC2, a protein involved in cholesterol intracellular trafficking) indicated that NPC2 might 
positively correlated with biliary cholesterol secretion[123]. This result was confirmed by the 
relationship between NPC2 protein levels and human biliary cholesterol concentration. Secreted 
NPC2 protein can stimulate ABCG5/G8 mediated cholesterol transport which can be explained 
that by binding to cholesterol, NPC2 can accelerate the transfer of cholesterol to micelles 
through ABCG5/G8[123]. In humans, rabbits, hamsters and many other species with expression 
of CETP, cholesterol ester can be transferred to larger size lipoproteins from HDL. Hence 
cholesterol will be either go back to forward cholesterol transport pathway or to the liver 
through apoB-containing lipoprotein receptors, indicating that LDL receptor might also be 
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involved in RCT[124]. However, the role of apoB-containing lipoprotein pathway in humans is far 
unclear. Finally, bile is secreted into intestinal lumen for fecal loss or reabsorption. 
Collectively, the studies in the past decades provide enough evidences that RCT needs 
to redefinition[125]. Elimination of cholesterol may not only be through hepatobiliary pathways, 
but via an alternative pathway, Transintestinal Cholesterol Excretion (TICE).  
1.3.3 Transintestinal Cholesterol Excretion (TICE) 
1.3.3.1 Definition of TICE 
Part of dietary and synthesized cholesterol is absorbed and transported back to 
circulation and the remaining will be excreted as neutral sterol or bile acids. Like mentioned 
above, ABCG5/G8 transporters mediate the process of cholesterol efflux to bile and 
hepatobiliary cholesterol would be dramatically eliminated when this transporter is absent[126]. 
Hence, inhibition of ABCG5/G8 should lead to a drastic lowering of fecal neutral sterol loss. 
Surprisingly, ABCG5/G8 double KO mice with diminished hepatobiliary cholesterol transport did 
not show the expected low levels of fecal neutral sterols[22]. Similar result was observed in 
ABCB4-/- mice. ABCB4 is a phospholipid transporter which located at the canalicular membrane 
of the hepatocytes. Biliary phospholipid is almost undetectable in ABCB4-/- mice and biliary 
cholesterol is absent in these mice as well due to lack of efficient cholesterol acceptor[127]. 
Interestingly, certain amount of intravenously injected radiolabeled cholesterol was recovered 
in feces of ABCB4-/- mice[128]. Niemann-Pick C1-like 1 (NPC1L1) is the protein expressed mainly 
in intestine which is required for cholesterol absorption. Hepatic NPC1L1 localizes to the 
hepatocytes canalicular membrane and allows retention of biliary cholesterol so that mice 
overexpress NPC1L1 have abrogated biliary cholesterol. However, the fecal neutral sterol levels 
were very well maintained compared to WT mice[129]. These findings demonstrated that 
hepatobiliary cholesterol excretion pathway is be the only route for cholesterol elimination. 
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With disturbed biliary cholesterol secretion, there must be an alternative direct pathway for 
cholesterol excretion- Transintestinal Cholesterol Excretion (TICE). 
The existence of TICE has been proposed about one century ago. As early as 1927, 
Sperry reported a surprising finding that dogs with bile fistula excreted much more cholesterol 
into feces than control dogs (Sperry WM. Lipid excretion IV. A study of the relationship of the 
bile to the fecal lipids with special reference to certain problems of sterol metabolism. J Biol 
Chem 1927; 1:351–378.). This result was confirmed about half a century late by Pertsemlidis et 
al. with the similar dog model[130]. Similarly, nondietary originated sterol present in the feces 
of patients with biliary obstruction[131]. However, these findings did not draw much attention 
because these models had incomplete enterohepatic cycle of biliary components. In particular, 
absence of bile acids would affect cholesterol absorption and consequently intestinal 
cholesterol synthesis. This is probably why these observations have been unnoticed for a long 
time in the literature. In conclusion, TICE can be defined as a process of cholesterol efflux 
directly from blood to intestinal lumen for elimination bypassing hepatobiliary pathways. 
1.3.3.2 Cholesterol origin of TICE 
TICE was directed measured in intestinal perfusion studies in which bile was diverted 
and bile duct was ligated. Van der Velde et al. proved that TICE occurs primarily and 
quantitatively most at the proximal part of intestine although the rest part of intestinal also 
excrete cholesterol to some extent. 
It is worth noting that intestinal cell cholesterol synthesis does not account for the 
secreted cholesterol and TICE route plays an even more important role than hepatobiliary 
route[132, 133]. Van der Veen et al. demonstrated this by quantification of cholesterol efflux 
from bile and plasma to feces by using isotope methodology in vivo[133]. The increased fecal 
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neutral sterol loss of these animals could not be explained by increased fecal loss of de novo 
synthesized cholesterol but could be directly from blood via intestinal mucosa[133]. However, 
which lipoproteins, if any, contribute to this route is currently unknown. 
1.3.3.2 Transport of cholesterol from blood to intestine 
TICE is a specific process for cholesterol elimination from the body and may involve 
transport protein activity from both basolateral and apical surface of enterocytes. 
SR-B1 is known very well as an acceptor for cholesterol uptake from lipoproteins and 
HDL, in particular, appears to be the more effective ligand[134, 135]. SR-B1 localizes both 
basolateral and apical membranes in Caco-2 cells, suggesting a potential involvement in 
intestinal lipoprotein uptake[136]. Mice fed with Western-diet or a high fat diet have 
upregulated TICE rates, in which intestinal SR-B1 mRNA levels and protein levels are positively 
correlated with TICE[137]. Unexpectedly, SR-B1 deficient mice have significantly increased TICE 
compared to controls[137]. In addition, mice overexpressed SR-B1 specifically in small intestine 
have increased TICE compared to WT mice when treated with ezetimibe to block cholesterol 
absorption. However, these mice have similar fecal neutral sterol levels to their WT littermates 
when treated with ezetimibe[138]. When crossed with NPC1L1LiverTg mice, which have 
increased TICE, these double transgenic mice had similar biliary cholesterol concentration, 
cholesterol absorption and fecal neutral sterol levels[138]. From these findings, it can be 
concluded that SR-B1 overexpression is not positively correlated with increased TICE. 
Furthermore, TICE may not be stimulated by increasing SR-B1 in the gut. Thus, the role of HDL as 
cholesterol donor for intestine remains questionable. 
Another potential efficient lipoprotein receptor is LDLr due to the fact that LDL may also 
involve in RCT[124]. In a recent study, Le May’s group found that in the mice that LDLr 
expression was conditionally deficient by continues injection of PCSK9, TICE was accordingly 
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decreased. Similarly, when LDLr expression was conditionally increased by PCSK9 deficiency, 
reduced TICE was detected consistently. Surprisingly, they also detected an increased TICE in 
LDLr-/- mice[139]. Moreover, LXR activation was shown to increase TICE significantly, yet the 
intestinal LDLr protein levels were nearly abrogated due to the E3 ubiquitin ligase Idol 
action[128, 133]. These results indicate that the role of LDLr and probably LDL in stimulating 
TICE may need further studies. 
As to the lipoprotein donor for TICE, it had been previously reported that whole body 
ABCA1-/- mice which have abrogated circulating HDL levels maintain normal biliary and fecal 
cholesterol levels[120, 121]. Recently, Vrins and colleagues also showed that ABCA1-/- mice 
have unchanged TICE compared with WT littermates[140]. Current data suggest that raising HDL 
may not be a potential therapeutic target to increase TICE. In contrast, apoB-containing 
lipoproteins seem to enhance TICE. It has been reported that mice with liver specific knockdown 
of acyl-CoA:cholesterol acyltransferase (ACAT2) have normal biliary cholesterol secretion but 
increased fecal neutral sterol excretion, indicating a potential contribution to TICE[141]. In the 
same study, this liver specific ACAT2 knockdown mice accumulated a large amount of 
cholesterol originating from nascent VLDL in the small intestine compared to control mice[141]. 
In a follow-up study, ACAT2 liver specific knockdown mice fed with cholesterol containing diet 
had rapidly increased fecal neutral sterol levels accompanied with accordingly increased 
circulating apoB lipoproteins, but had no change on biliary cholesterol levels[142]. Microsomal 
triglyceride transfer protein (MTP) is required for apoB lipoprotein secretion. Hepatic 
knockdown of MTP in mice would decrease hepatic triglyceride secretion yet the biliary 
cholesterol levels was not affected[143]. However, fecal neutral sterol levels was significantly 
decrease in MTP and NPC1L1 liver specific knockout mice[143]. In conclusion, these results 
indicate that VLDL secretion is necessary for TICE. 
32 
 
Currently many questions related to the intestinal receptors and cholesterol donors 
involved in TICE remain unanswered. Defining the TICE lipoprotein donor and intestinal receptor 
systems has potential therapeutic significance. 
1.3.3.3 Transport of cholesterol from enterocyte to intestinal lumen 
In the process of cholesterol transport from enterocyte to intestinal lumen, cholesterol 
efflux protein ABCG5/G8 are thought to be the good candidate mediating cholesterol efflux. 
Transgenic mice overexpressing ABCG5/G8 had significantly increased fecal neutral sterol 
levels[23]. However, this increased excretion was inhibited by Mdr2 deficiency in the transgenic 
mice, suggesting that biliary cholesterol secretion contribute mostly in their fecal neutral sterol 
loss[144]. Moreover, ABCG5 and/or ABCG8 deficiency leads to mild[22, 145] or no[21] 
decreased fecal neutral sterol levels. Besides, both mRNA and protein levels of ABCG5/8 were 
not relevant to TICE rate in the same intestinal segments. In addition, with intestinal perfusion 
tool, TICE was directly measured in ABCG8-/- mice and found no differences compared to 
control mice[132]. Wang and colleagues recently highlighted the possible role of intestinal 
ABCG5/G8 in TICE. In the study, to determine the role of hepatic and intestinal ABCG5/G8 in RCT, 
liver (L-G5G8-/-), intestinal (I-G5G8-/-) and whole body (G5G8-/-) knockout mice were injected 
with 3H-cholesterol and they found that the percentage of 3H-cholesterol was in found highest 
in the WT and I-G5G8-/- mice, then the L-G5G8-/-, G5G8-/- had the least. Compared to WT mice, 
I-G5G8-/- mice had decreased fecal 3H-cholesterol excretion which was explained by reduced 
TICE[146]. Collectively, ABCG5/G8 are very likely to contribute to TICE particularly intestinal 
expressions. But their roles seem to strongly depend on the conditions and need more 
elucidation.  
ABCB1 is a multidrug transporter, locating at apical surface of enterocytes, which can 
pump cholesterol as a cholesterol floppase[147]. Mice with deficiency of ABCB1 for both 
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isoforms spontaneously develop hepatic steatosis, obesity, diabetes mellitus and increase HDL-C. 
Le May and colleagues reported that the mice with deficiency of ABCB1 had about 26.5% 
decreased TICE compared to WT mice, indicating a contributive role of ABCB1 in TICE[139]. 
1.3.3.4 Regulation of TICE 
Although the mechanisms for TICE have not been clear yet, it is found that TICE can be 
stimulated or inhibited by some factors. 
Van der Velde and the colleagues found that TICE increased two-fold in mice receiving 
Western type or a high fat diet. This results were positively correlated with the increased fecal 
neutral sterol levels in these mice as well. However, high cholesterol diet did not upregulate 
TICE as the other two types of diets. The authors concluded from these results that TICE rate is 
not dependent on cholesterol content in the diet but only fat content[137]. The increased fecal 
neutral sterol levels in mice when fed with high fat diet were demonstrated by de Vogel-van der 
Bosch at el, whereas all known cholesterol transporters expressions were decreased in these 
mice[148]. According to the authors, this results could not be explained by increasing TICE 
rather than decreasing cholesterol absorption. Connor and colleagues recruited male subjects 
with characteristic serum cholesterol concentrations without known metabolic disorders to 
investigate the effect of dietary fat on fecal neutral sterol levels. They found that poly-
unsaturated fats affect RCT by increasing fecal neutral sterol levels two-fold higher than 
cholesterol calculated to leave plasma[149]. This results were confirmed later by Nestel[150] 38 
and Oh and Monaco39. Since polyunsaturated fatty acids are natural ligands for peroxisome 
proliferator-activated receptors (PPARs), their findings may explain the study that PPARδ 
activation in mice led to increased TICE[151].  
Recently, two studies reported if ezetimibe, a clinically approved drug used to treat 
hypercholesterolemia through blocking NPC1L1 to decrease cholesterol absorption, increases 
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RCT through TICE pathway. Uto-Kondo et al. and colleagues found that Ezetimibe increased fecal 
macrophage-derived 3H-neutral sterol levels in bile duct-ligated hamsters[152]. However, this 
increase is not as significant as in sham-operated hamster. The authors concluded that 
ezetimibe can stimulate TICE and the effect will be maximized by the existence of hepatobiliary 
cholesterol secretion120. Overall, it can be concluded that fat content in the diet can increase 
TICE. Furthermore, blocking cholesterol absorption by ezetimibe can promote TICE but is likely 
to require hepatobiliary cholesterol secretion pathway to maximize the effects. 
Plosch and colleagues showed that liver X receptor (LXR) activation led to increase fecal 
neutral sterol excretion, which could not only be attributable to hepatobiliary cholesterol 
secretion. This result suggested a potential contribution in intestine to total cholesterol 
elimination[153]. This result was demonstrated by Kruit and colleagues who showed that LXR 
activation induced increased fecal neutral sterol loss was independent of biliary cholesterol 
secretion[128]. With a kinetic approach to measure cholesterol efflux rates, Van der Veen et al. 
reported that LXR activation stimulated TICE as well[133]. Collectively, these findings suggest 
that LXR is involved in TICE. 
It was reported that the intracellular vesicle transport proteins, Rab9 and LIMPII were 
upregulated when TICE was enhanced[151]. However, to determine their role in TICE, more 
studies with intestinal specific knockout mice for these proteins are required. 
In conclusion, there are many factors that can significantly stimulate TICE, suggesting a 
promising approach to consider TICE acceleration as a potential effective therapy particularly in 
patients with deficient biliary cholesterol excretion. 
1.3.3.5 TICE in humans 
Early in 1959, fecal sterols from nondietary cholesterol origin was found in feces of 
patients with biliary obstruction[131], which may be the first evidence suggesting the existence 
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of TICE in human. However, it remains unclear if TICE presents in normal healthy conditions and 
whether it can be stimulated. In 1967. Simmonds et al. performed intestinal perfusions in 
humans and detected significant cholesterol secretion in intestine yet the amount of secreted 
cholesterol was not quantified[154]. Based on the average total estimated cholesterol secreted 
from body per day (1g)[155, 156], average daily cholesterol intake amount (400 mg)[157] biliary 
cholesterol secretion amount (1000mg)[158] and cholesterol absorption rate (50%)[155], Van 
der Velde and colleagues calculated the possible amount of cholesterol secreted from intestine 
in human per day[159] which is about 300mg/day. Given 70kg body weight, this amount is 
about one-third of the biliary cholesterol secretion amount. However, studies on quantification 
of this amount need to be performed in humans. 
If this data can be confirmed, stimulation of TICE in human may suggest a new 
therapeutic approach to reduce hypercholesterolemia especially in the patients with deficient 
biliary cholesterol secretion. TICE has never been tested to predict plasma cholesterol. The 
measurement of cholesterol kinetics in humans by stable isotype studies may provide new view 
of regulation of plasma cholesterol, which will also provide foundation of new therapeutic 
strategies to treat hypercholesterolemia and atherosclerosis associated CVD in humans. 
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CHAPTER II. Dietary medium-chain triglycerides promote oral allergic sensitization and orally 
induced anaphylaxis to peanut protein in mice. 
2.1 Introduction 
Peanut allergy affects about 2% of the Western population, and its prevalence is rising [160-163]. 
The condition is rarely outgrown and there is no cure. To stem the rise of food allergies, it is 
important to unravel mechanisms that lead to allergic sensitization. Peanuts and many 
allergenic foods contain significant amounts of triglycerides (“fat”) or are most likely ingested 
with a fat-rich meal, especially in Western societies, which are also more affected by food 
allergies. However, little is known about the effect of dietary fat in allergic sensitization or 
immune responses to dietary proteins.  
Recent work has demonstrated that the intestinal epithelium plays a key role in immune 
responses to dietary antigens. Intestinal epithelial cells control access of luminal antigenic 
material to the lamina propria and beyond, and it has been suggested that increased intestinal 
permeability could be a risk factor for allergic sensitization [164, 165]. On the other hand, 
properly controlled intestinal absorption of small amounts of dietary antigen may protect 
against food allergies by promoting oral tolerance [166]. However, the mechanisms involved in 
soluble antigen absorption are poorly understood.  
Fatty acids, released in significant amounts from dietary triglycerides in the upper gastro-
intestinal tract, have potent detergent properties and may induce transient mucosal damage 
and gut leakiness [167] which could enable translocation of dietary antigen. The type of dietary 
fat might determine antigen absorption. We recently observed that dietary long-chain 
triglycerides (LCT), which contain fatty acids that have more than 12 C-atoms and are absorbed 
via mesenteric lymph as part of chylomicron particles, promoted the absorption of the dietary 
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antigen ovalbumin (OVA) into lymph and blood [168]. In contrast, dietary medium-chain 
triglycerides (MCT; fatty acids with 12 or fewer C-atoms), which are absorbed via portal blood, 
promoted less antigen absorption [168]. This would suggest that MCT should differ from LCT in 
their effects on allergic sensitization and anaphylaxis. 
Fatty acids of different chain length may also differ in pharmacological properties, especially in 
their effects on the intestinal epithelium with which they interact in large numbers. Intestinal 
epithelia not only control antigen absorption, but also secrete factors that significantly affect 
nearby immune cells. For example, the intestinal epithelial cytokine TSLP (Thymic Stromal 
Lymphopoietin) promotes the induction of Th2- responses through multiple mechanisms [169]. 
Interestingly, TSLP has been implicated in allergic diseases, including experimental food allergy 
[170]. Other Th2-biasing cytokines, such as IL-25 (IL-17E) and IL-33, are also expressed in the 
intestinal epithelium, and support Th2-mediated expulsion of parasitic worms[171, 172]. Fatty 
acids are known to affect intestinal epithelial cytokine expression [173, 174], although it is 
unclear how epithelial cytokines relevant to food allergy are regulated. 
Based on these putative immune-modulating effects of dietary fat, we evaluated how dietary 
fats affect oral sensitization in naïve mice and immune responses to oral antigen challenges in 
sensitized mice. We decided to compare LCT with MCT, based on their different effects on OVA 
absorption. As model system for oral sensitization we slightly modified a recently reported, 
adjuvant-free model[175]. This model and a classical systemic sensitization model were also 
used to test the effect of triglycerides during oral antigen challenges. To acutely block 
chylomicron formation during LCT feeding, a small amount of the chylomicron secretion 
inhibitor PL81 was added in some experiments[168, 176, 177].  
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Interestingly, when we replaced LCT in peanut butter with MCT or gavaged OVA with MCT, we 
observed marked allergic sensitization, which was associated with a significant induction of 
intestinal epithelial Th2 cytokine expression in the jejunum, a reduction of antigen absorption 
into blood, and an increase in antigen absorption into Peyer’s patches. LCT did not induce 
sensitization unless PL81 was added. Moreover, our data suggest that chylomicron formation 
during antigen ingestion may promote oral tolerance and may protect against allergic 
sensitization.  
2.2 Methods 
2.2.1 Animals 
Experiments with peanut protein were performed with male C3H/HeJ mice. Experiments with 
OVA used male C3H/HeJ mice, female BALB/c mice and DO11.10 mice (BALB/c background) of 
both genders, and female Sprague-Dawley (SD) rats. Approximately 70% of CD4 T-cells of the 
transgenic DO11.10 strain express a T-cell receptor for an OVA peptide (residues 323-339) [178]. 
The mice, ordered at 5 weeks of age from The Jackson Laboratory, were housed three per cage 
in a room of a specific pathogen-free animal facility with a 12h light / dark cycle, and were used 
at 6 weeks of age. Rats were purchased from Taconic. Unless indicated otherwise, the animals 
received standard rodent diets and filtered tap water ad libitum. All animals were handled in 
strict accordance with good animal practice as defined by the relevant national and local animal 
welfare bodies, and all animal work was approved by the Institutional Animal Care and Use 
Committee of the University of Kentucky (Animal Welfare Assurance Number of the University 
of Kentucky A3336-01; U.K. IACUC protocol 2008-0306). 
2.2.2 Gavage suspensions and diets 
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Gavages: Jif-brand peanut butter or grade V OVA (Sigma Aldrich Corp.) were used for gavage 
studies. Peanut butter was diluted with two volumes of MCT oil (distilled coconut oil, Nestle 
Nutrition Corp.) and passed through a sieve with a 70 µm pore size to prevent clogging of the 
feeding tube. The filtrate was centrifuged (4 minutes; 16,800xg) and the supernatant replaced 
with triglycerides or water to reconstitute the initial volume of peanut butter. Triglycerides 
consisted of MCT oil or LCT (food grade peanut oil; “Hollywood” brand). In some cases, PL81 was 
added at 3% by volume to LCT to block chylomicron secretion into lymph [168, 176, 177]. We 
found this quantity to completely block chylomicron formation without toxic side effects [168, 
177].  
Diets: All diets were from Harlan Teklad Corp. Their standard rodent diet, with casein as protein 
source and soybean oil as fat source, was considered the LCT diet. The MCT diet differed only in 
fat source (partially hydrogenated coconut oil instead of soybean oil). In OVA studies, 10% of 
casein was replaced with egg-white solids (Deb-El brand). In peanut feeding studies, 10% of 
casein was replaced with defatted peanut flour (Byrd Mill brand) and soybean oil was replaced 
with peanut oil. 
2.2.3 Allergic sensitization  
By acute feeding: Mice were fasted for 4h, then gavaged once with 0.3 ml of antigen 
suspensions in various vehicles (~80 mg peanut protein or 60 mg OVA). An 18G 38mm 
polypropylene feeding tube with rounded tip (Harvard Apparatus Corp.) was used to avoid injury. 
Mice were returned to standard diets and blood was drawn 18 to 21 days later for antibody 
measurements. In some instances (as indicated), mice received a second oral sensitization one 
week after the first. By chronic feeding: Mice were fed MCT- or LCT- based peanut or control 
diets for 4 weeks, with weekly blood sampling. By systemic sensitization: Mice received two 
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intraperitoneal (I.P.) injections with 10 µg OVA in 0.2 ml alum (Accurate Chemical and Scientific 
Corp.), with one week between injection. One week later, blood was tested for anti-OVA IgE. 
Rats were sensitized by a single subcutaneous injection with 0.1 mg OVA and 1 mg alum in saline 
and their blood was obtained two weeks later after euthanasia. Serum was also obtained from 
non-sensitized animals. 
2.2.4 ELISA for antigen-specific IgE and IgG 
To detect antigen-specific IgE and IgG, we developed an ELISA, which involved coating 96 well 
BD Falcon ELISA plates with 20 µg peanut butter protein or 20 µg OVA in carbonate buffer (pH 
9.6). Washed plates were treated with blocking solution (“NAP blocker”, GBiosciences Corp.), 
and mouse serum, diluted 1:500 in blocking solution for IgG measurements and 1:10 for IgE 
measurements, was added for 1 h at room temperature. Unbound antibody was washed with 
Tris-Buffered Saline containing Tween 20 (TBST). Alkaline-phosphatase conjugated rabbit anti-
mouse IgG (1:5000; A1902, Sigma-Aldrich.) or goat anti-mouse IgE (1:800; SouthernBiotech 
Corp.) were added in blocking solution, and incubated for 60 min or longer at room temperature 
in complete darkness (in case of IgE sometimes several hours). After washing unbound antibody, 
AP substrate (femto-ELISA-AP Substrate; GBiosciences) was added and the absorption at 450 nm 
(A450) was read after addition of 50 µl stop solution (3 M NaOH).  
2.2.5 In vitro splenocyte stimulation assays 
Spleens were aseptically removed, gently minced, and passed through a 70 µm mesh into 
culture medium (Dulbecco’s Modified Eagle’s Medium:F12 (1:1; Lonza Corp.) with 10% heat-
inactivated fetal calf serum (Gibco Corp.) and antibiotics (Gibco)). Cell viability was assessed 
with Trypan Blue staining. Splenocytes were seeded in 96-well plates at 1 x 106 live cells/cm2 and 
kept in an incubator maintaining 100% humidity, 37ºC, and 5% atmospheric CO2. Cells were 
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pulsed with homogenized peanut butter (50 µg protein / ml) or 1 µg / ml OVA peptide 323-339 
(Invivogen Corp) or vehicle (control), and medium obtained 4 days after the pulse was analyzed 
for cytokine content (ELISA kits from eBiosciences). 
2.2.6 In vitro basophil stimulation assays 
RBL-2H3 cells, a rat leukemia line with basophil and mast-cell characteristics, were obtained 
from American Type Culture Collection and grown till confluency in 96 well tissue culture plates 
in Eagle’s Medium with 10% heat-inactivated serum and antibiotics. They were exposed to 
serum from OVA-sensitized rats (1:1 dilution) or naïve rats for two hours, washed twice with PBS 
containing 0.1% BSA, then incubated with 0.1 ml of serial dilutions of OVA in PBS/BSA, for 1h. 
Included with the OVA was an emulsion with chylomicron-like composition and physiological 
properties [Robinson, 1979 #886] (Intralipid 20%; Baxter Healthcare) at 1:1000 or 1:500 dilution. 
One hour after the incubation, 30 µl medium was mixed with 30 µl 4-nitrophenyl-N-acetyl-β-D-
glucosaminide (Sigma Aldrich; 1 mg / ml in citrate buffer, pH 5) and the coloring reaction was 
stopped after 1h with carbonate buffer (pH 10.5). p-Nitrophenol was subsequently quantified by 
measuring the optical density at 405 nm. OD405 values of OVA-free solutions were subtracted 
to correct for light absorption by emulsion particles. The emulsions were non-toxic at the 
indicated dilutions as reflected by lack of stimulation of spontaneous hexaminidase release and 
the cells’ appearance after incubation was identical to controls (not shown). 
2.2.7 In vivo antigen challenges 
For systemic challenges, mice received 30 mg peanut butter protein I.P. in 0.3 ml sterile 
PBS[175]. Body temperature was measured telemetrically immediately before and every 5 
minutes after the challenge, using subcutaneously placed micro transponders (Bio Medic Data 
Systems Corp.), and mast cell histamine release was estimated by measuring mouse mast-cell 
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protease 1 (mmcp-1) serum levels 90 minutes after the challenge [175] (eBioscience ELISA). 
Signs of anaphylaxis were estimated with a semi-quantitative scoring, with “0” being assigned to 
mice with no symptoms, “1” to mice which were stationary but moved when provoked, “2” to 
mice which remained immobile even when provoked, and “3” to mice lying on their side. 
In some experiments, mice were injected ip 16h before the challenge with rat-monoclonal 
blocking antibodies against IgE (clone EM-95; 0.1 mg/mouse) or-FcJRII/III (clone 2.4G2; 0.5 
mg/mouse), to determine whether anaphylaxis was IgE- or IgG- dependent. These antibodies 
have been described elsewhere [179, 180].  
For oral challenges with peanut protein, 80 mg peanut butter protein was resuspended in 0.3 ml 
vehicle. For oral challenges with OVA, 50 mg OVA was suspended in 0.15 ml water and mixed 
with 0.15 ml triglycerides.  
2.2.8 Effect of triglycerides on epithelial Th2 cytokine expression 
To study acute effects of dietary fat on intestinal epithelial cytokine expression, fasted mice 
were gavaged with 0.3 ml MCT or LCT (with or without PL81) and jejuna were obtained 5 h later. 
To study chronic effects, mice were fed 3 wks with MCT or LCT diets and intestines were 
obtained from non-fasted mice in the morning. Epithelia were isolated by treating washed 
sections with 1 mM dithiothreitol and 30 mM Ethylenediaminetetraacetic acid as described 
elsewhere [181]. Epithelial RNA was isolated with an EZRNA kit (Omega-Biotech Corp.) and 
reverse-transcribed into cDNA with a Q-script kit (Quansys Corp.). The cDNA was analyzed for 
abundance of TSLP, IL-25 and IL-33 mRNA relative to GAPDH with primer pairs ACG GAT GGG 
GCT AAC TTA CAA / AGT CCT CGA TTT GCT CGA ACT (TSLP), ACA GGG ACT TGA ATC GGG TC / 
TGG TAA AGT GGG ACG GAG TTG (IL-25), ATT TCC CCG GCA AAG TTC AG / AAC GGA GTC TCA 
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TGC AGT AGA (IL-33) and CCA GGT TGT CTC CTG CGA CTT / CCT GTT GCT GTA GCC GTA TTC A 
(GAPDH) using a Bio-Rad CFX-96 realtime quantitative polymerase chain reaction machine.  
2.2.9 Effect of triglycerides on Th2 responses 
To test the effect of MCT on Th2 responses to dietary antigen, DO11.10 mice were fed egg 
protein-containing MCT or LCT diets (or corresponding egg-free diets) for one week and spleen 
cells were challenged ex vivo with OVA peptide or not. Cytokines in the culture supernatants 
were quantified by ELISA (eBioscience). 
2.2.10 Effect of triglycerides on antigen absorption 
Peanut butter protein was labeled with 125I according to a slightly modified iodine monochloride 
procedure [182]. Prior to protein labeling, the peanut butter was delipidated with hexane - 
isopropanol (2:1), resuspended in phosphate-buffered saline (PBS), dialyzed against PBS, and 
concentrated with a 10 kDa ultra filter. Fasted C3H/HeJ mice were gavaged with 80 mg peanut 
butter protein spiked with radiolabeled protein, suspended in 0.3 ml triglycerides. Plasma 125I 
levels 30 minutes after gavage were measured in a gamma counter. Absorption was expressed 
as percentage of gavaged material. Absorption of OVA was studied using DQ-OVA (Invitrogen), 
which only emits fluorescence when degraded in lysosomes. For this, fasted BALB/c mice 
received gavages of 1 mg DQ-OVA in water, MCT, LCT, or LCT + PL81, and were then deprived of 
food for at least another hour. The next day, single cell suspensions from mesenteric lymph 
nodes (MLN), Peyer’s patches and spleen were stained with Alexa 647 anti-CD11c (Biolegend 
Corp.) and analyzed by flow cytometry (FACScalibur, Becton Dickinson corp.).  
2.2.11 Statistics 
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Results were analyzed with Graphpad Prism version 5 and are displayed as average ± S.E.M. 
ANOVAs were followed by between-group post-hoc analyses (Newman-Keuls). Anaphylaxis 
scores were compared with Mann–Whitney U tests. Temperature data were analyzed by 
comparing maximum temperature drop or area under the curve. Columns in graphs that do not 
share letter labels differ significantly from each other (P<0.05).  All figures show representative 
results of at least two repeats per experiment. 
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2.3 Results 
2.3.1 MCT and LCT differentially affect antigen absorption and dissemination 
MCT were previously found to decrease absorption of dietary OVA into blood compared to LCT 
[168]. To test whether this also applies to peanut protein, radiolabeled peanut protein was fed 
to fasted mice together with MCT, LCT, or LCT + PL81, and blood was collected 30 min later. As 
shown in Fig 2.1A, gavage with MCT resulted in significantly reduced antigen absorption 
compared with LCT. However, addition of PL81 to LCT (which trapped chylomicrons within 
jejunal epithelial cells; Fig 2.1B) reduced absorption to levels seen with MCT (which does not 
cause chylomicron release).  
To further test the effect of postprandial chylomicron formation on antigen absorption, we 
measured DQ-OVA uptake by antigen presenting cells one day after DQ-OVA gavage in the 
presence of different triglycerides. Surprisingly little signal was found in the MLN of either group 
(<1% positive cells positive), with slightly stronger signal in the spleen (approximately 3%). 
However, there were no significant differences between groups for any of these sites (not 
shown). In contrast, a pronounced difference was observed in the percentage of DQ-OVA 
positive cells in the Peyer’s patches among groups, with significantly more DQ-OVA-positive cells 
after gavage with MCT and LCT + PL81 than after gavage with water or LCT (Fig 2.1C).  Thus, 
prevention or inhibition of chylomicron formation suppressed antigen absorption into the 
circulation while enhancing antigen delivery to Peyer’s patches.  
2.3.2 Dietary MCT promote allergic sensitization  
Because MCT and LCT differed in their effects on antigen absorption, we next evaluated their 
effects on immune responses to dietary antigens. Strikingly, antigen-naïve male C3H/HeJ mice 
gavaged once with peanut protein (80 mg) in MCT produced significantly more IgE and IgG  
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Figure 2.1 Effects of triglycerides on antigen absorption. A, Plasma iodine 125 levels 30 minutes 
after gavage of radiolabeled peanut protein with indicated vehicles (n = 6). B, Features of mice 
intestines and epithelial cells in PBS 30 minutes after gavage with indicated vehicles. PL81 blocks 
LCT absorption, as reflected by increased buoyancy because of lipid entrapment. Tissue was 
obtained 5 hours after gavage. C and D, CD11c+ and DQ-OVA+ cells in Peyer patches 16 hours 
after DQ-OVA gavage in indicated vehicles (n = 4). 
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against peanut protein than mice gavaged with the same amount of protein in LCT or water (Fig 
2.2A, B). Usage of another LCT, soy oil, yielded the same results (Fig 2.2C). The protective effect 
of LCT was abrogated by adding PL81 (Fig 2.2A, B). In addition, splenocytes from mice gavaged 
with peanut protein in MCT produced more IL-13 when stimulated in vitro (Fig 2.2D). The failure 
to induce sensitization with LCT may involve induction of oral tolerance by LCT, since a single 
gavage of peanut protein in LCT prevented subsequent sensitization by antigen in MCT (Fig 2.2E). 
Interestingly, the pro-allergenic effect of MCT was not limited to peanut protein, since a single 
gavage of OVA (60 mg) in MCT or LCT + PL81 also resulted in increased IgE anti-OVA antibody 
production compared to gavage in water or LCT (Fig 2.2F).  
Collectively, these data suggest that dietary MCT promotes allergic sensitization to food 
antigens and that chylomicrons may prevent sensitization. 
2.3.3 Dietary MCT promote intestinal epithelial Th2 cytokine expression and Th2 bias 
Recent reports indicated that intestinal epithelial cells can contribute to allergic sensitization by 
releasing cytokines that promote Th2 responses [170]. To determine whether the sensitizing 
effect of MCT was associated with increased TSLP expression, we measured intestinal epithelial 
TSLP mRNA in jejunal epithelia 5h after gavage with MCT or LCT. As shown in Fig 2.3A, mice 
gavaged with MCT had significantly higher TSLP mRNA in jejunal epithelial cells than mice 
gavaged with LCT, unless PL81 was added (Fig 2.3B). 
We next tested whether chronic MCT feeding also stimulates intestinal epithelial TSLP mRNA 
expression. Indeed, C3H/HeJ mice fed three weeks with the MCT diet had significantly higher 
levels of TSLP mRNA in their duodenal and jejunal epithelia than control mice (Fig 2.4A). TSLP, 
which is more highly expressed in the distal gastrointestinal tract [183], was not upregulated by 
MCT in sites distal from fat absorption. There was also a stimulatory effect of MCT on IL-25 and  
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Figure 2.2. MCT causes allergic sensitization. A-C, Anti-peanut antibodies 18 days after gavage 
with peanut protein (80 mg) in indicated vehicles (n = 6). The LCT was peanut oil in Fig 2, A and B, 
and soybean oil in Fig 2, C. D, Splenocyte IL-13 release (n = 4). ∗P < .05. E, Gavage of peanut 
protein in the LCT (OT) 1 week before gavage with the MCT induces oral tolerance (n = 6). F, 
Anti-OVA IgE levels 18 days after gavage with OVA (60 mg) in indicated vehicles (n = 6). 
OT Oral tolerance 
LCT/P LCT plus PL-81 
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Figure 2.3. Tslp mRNA in epithelial cells of the jejunum 5 hours after gavage of 0.2 mL of the 
MCT, the LCT, or saline (A) or 0.2 mL of the LCT, the LCT plus PL81, or saline plus PL81 (B; n = 6). 
  
50 
 
IL-33 mRNA expression (Fig 2.4B). However, TSLP protein levels were below the level of 
detection by ELISA (not shown). 
The sustained effect of MCT on epithelial cytokine expression prompted us to test whether 
addition of peanut protein to MCT diets would cause sensitization during sustained dietary 
exposre. Indeed, C3H/HeJ mice receiving peanut protein in the context of MCT had detectable 
amounts of anti-peanut IgE in their serum after 4 weeks (Fig 2.4C).Thus, dietary MCT promote 
allergic sensitization, which partially involves upregulation of expression of Th2-biasing 
cytokines in the epithelium of the jejunum. To investigate whether dietary MCT causes a general 
Th2 bias, we fed DO11.10 mice with MCT- or LCT- diets with or without egg-white protein for 1 
week and then stimulated splenocytes ex vivo with OVA peptide. In the absence of OVA peptide, 
none of the splenocyte preparations produced detectable IL-4 or IFN-J (Fig 2.5). In contrast, 
stimulation with OVA peptide resulted in significant production of these cytokines, due to the 
large numbers of OVA-reactive CD4 T-cells in DO11.10 mice. However, splenocytes from mice 
fed MCT diets with OVA produced more IL-4 and less IFN-Jthan the LCT/OVA diet, suggesting 
that dietary MCT had indeed promoted Th2 responses to the antigen.  
2.3.4 IgG-dependent anaphylaxis upon systemic antigen challenge 
We next tested whether sensitized mice would develop anaphylaxis upon antigen re-exposure. 
Mice (C3H/HeJ) were gavaged once with peanut protein in MCT, LCT, or LCT plus PL81, then 
challenged I.P. 18 days later with 30 mg peanut protein in 0.2 ml PBS. As shown in Figure 6A and 
B, mice sensitized with peanut protein in MCT or LCT+PL81 released much more mmcp-1 into 
the bloodstream and showed a greater drop in body temperature than mice sensitized by 
gavage with peanut protein in LCT. Semi-quantitative clinical scoring of anaphylaxis (based on 
mouse mobility) in a separate experiment yielded negligible scores in mice sensitized with  
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Figure 2.4. Effect of MCT feeding on intestinal epithelial TH2 cytokine expression. A, TSLP 
mRNA in epithelia from indicated sections 3 weeks after feeding (n = 5). B, IL-25 and IL-33 mRNA 
in jejunal epithelial cells 3 weeks after feeding (n = 5). C, IgE against peanut protein during 4 
weeks of feeding with diets enriched with peanut flour (n = 6). 
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Figure 2.5. Promotion of TH2 responses by dietary MCTs. DO11.10 mice were fed MCT- or LCT-
based diets containing egg white (MCT+egg and LCT+egg) or without egg white (MCT and LCT; 
n = 5 per group). One week later, splenocytes were stimulated ex vivo with OVA peptide, and 
indicated cytokines were measured by using an ELISA. 
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peanut protein in water or LCT, while mice sensitized with MCT or LCT plus PL81 had 
significantly increased scores upon challenge (Fig 2.6C). However, diarrhea or significant stool 
softening was not evident in any group. To determine whether anaphylaxis was IgE- or IgG-
dependent, mice sensitized by gavage of peanut protein in MCT were treated 16h before the 
systemic challenges with rat monoclonal antibodies that block IgE- (EM-95) or IgG- mediated 
pathways of anaphylaxis (2.4G2), or both [184]. As shown in Fig 2.6D, anaphylaxis was 
prevented when the mice were pre-treated with anti-FcJRII/III, but not anti-IgE, suggesting that 
anaphylaxis was IgG-dependent. The mild drop in body temperature in naïve mice may relate to 
complement activation by peanut protein [185]. 
2.3.5 IgE- dependent anaphylaxis upon oral antigen challenge  
Next, we tested whether mice sensitized by gavage of peanut protein in MCT develop 
anaphylaxis when re-exposed to antigen via the oral route. To this end, mice were gavaged with 
peanut protein in MCT on day 1 and 8 (double sensitization), and injected 40 days later with IgE-
blocking antibodies or vehicle. One day later, the mice received a third gavage with peanut 
protein in MCT, and body temperature was monitored. As shown in Fig 2.7A, oral antigen 
challenged mice showed a significant drop in body-temperature, provided that no blocking 
antibody had been injected. In contrast, mice pre-treated with blocking antibodies against IgE 
did not respond to the oral antigen challenge, suggesting that orally-induced anaphylaxis was 
IgE- dependent. It should be emphasized that sensitization in this experiment was enhanced by 
performining two gavages with MCT, separated by one week. In contrast, gavage with peanut 
protein in LCT prior to gavage with MCT led to tolerance (Figure 2.2D). 
Orally induced anaphylaxis is exacerbated when chylomicron formation is inhibited 
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To test how MCT might affect responses to oral antigen challenge, mice sensitized by two 
gavages with peanut protein in MCT were orally challenged 40 days later with peanut protein in 
water, LCT (peanut oil), MCT, or LCT + PL81 (Fig 2.7B). In agreement with the experiment in Fig 
2.7A, mice challenged with peanut protein in MCT showed a significant drop in body 
temperature (Fig 2.7B). On the other hand, mice challenged with peanut protein in water or LCT 
showed no significant response. However, when PL81 was added to LCT, the response was 
similar to that with MCT (Fig 2.7B, C). Chylomicron formation may have protected against 
anaphylaxis, most likely by inhibiting the ability of absorbed antigen to gain access to mast cells 
or basophils. In vitro studies indeed revealed that basophils decorated with anti OVA IgE 
responded significantly less when OVA was added in the presence of chylomicron-like particles 
(Fig 2.7D). Moreover, in an OVA-based model of food allergy it was observed that allergic 
responses were significantly more severe when challenges occurred with MCT or LCT + PL81 
than with LCT alone (Fig 2.7E). In particular, the response of mice challenged with MCT was very 
robust. 
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Figure 2.6. IgG-dependent anaphylaxis upon systemic challenge. Mice were gavaged once 
with peanut butter protein in indicated vehicles and then challenged by means of 
intraperitoneal injection 18 days later (n = 6). A-C, Parameters included plasma mouse 
mast cell protease 1 (mmcp-1) 90 minutes after the challenge (Fig 6, A), body 
temperature (Fig 6, B), and clinical score (Fig 6, C). D, Pretreatment with blocking 
antibodies against IgG receptors (2.4G2) but not against IgE (EM-95) blunted anaphylaxis. 
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Figure 2.7. IgE-dependent orally induced anaphylaxis is aggravated by MCTs. A, Body 
temperature of mice (n = 6-7) challenged with peanut protein in the MCT with or without 
pretreatment with IgE blocking antibody. Sensitization occurred by means of gavage on days 1 
and 8, and challenges were performed on day 48. B, Mice (n = 6) were sensitized as in Fig 7, A, 
but the oral challenge was performed by using gavage of peanut protein in different vehicles. C, 
Plasma mouse mast cell protease 1 (mmcp-1) levels in mice in Fig 7, B. D, Inhibition of basophil 
activation by including Intralipid (2 different dilutions) with OVA added to sensitized basophils 
(n = 4 per group). E, BALB/c mice (n = 9 per group) were sensitized intraperitoneally with OVA in 
alum and then challenged with 60 mg of OVA by means of gavage in the indicated vehicle. All 
experiments were repeated at least twice with similar outcome, except those shown in Fig 7, B 
and C, which were performed once. 
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2.4 Discussion 
In addition to confirming and expanding our previous observation that more antigen is absorbed 
when ingested with LCT than with MCT[168], we have made six novel and important 
observations: 1) antigen delivery to Peyer’s patches is significantly enhanced by MCT; 2) both 
acute and chronic MCT feeding promote allergic sensitization to concomitantly ingested 
antigens, as shown by increased antibody production and anaphylaxis following antigen re-
exposure; 3) ingestion of antigen with MCT promotes the expression of the Th2-biasing 
cytokines TSLP, IL-25 and IL-33 by upper gastrointestinal tract epithelial cells; 4) MCT-based 
diets induce a Th2 bias in the host (probably a result of point 3); 5) MCT promote the ability of 
ingested antigen to induce anaphylaxis in sensitized mice; and 6) almost all MCT effects are 
mimicked by mixing LCT with an inhibitor of epithelial cell chylomicron secretion, suggesting 
that chylomicons inhibit antigen access to mast cells, basophils and dendritic cells that present 
antigen in a stimulatory manner. Each of these points and its relevance is discussed below. 
Antigen absorption: We previously demonstrated that chylomicron formation promotes 
intestinal antigen absorption into the bloodstream [168]. We now additionally demonstrate that 
failure to secrete chylomicrons causes retention of LCT (and presumably, associated antigens) 
within the intestinal mucosa and lamina propria, where they could more readily interact with 
relevant immune cells. A similar mechanism may also explain how feeding MCT instead of LCT 
increases antigen within Peyer’s patches. The role of Peyer’s patches in food allergy is unclear, 
although they are reported to be associated with oral tolerance [186, 187]. We found, however, 
that DQ-OVA was present in a large fraction of Peyer’s patch dendritic cells, when gavaged with 
MCT or LCT plus PL81. In contrast, surprisingly few DQ-OVA positive cells were found in the MLN, 
even when DQ-OVA was gavaged with LCT. The apparent conflict between the latter observation 
and our previous finding of increased OVA in the MLN of OVA/LCT-gavaged mice may be 
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explained by the possibility that chylomicrons traffic through the MLN but prevent the uptake or 
processing of associated antigens by MLN dendritic cells.  
Sensitization by MCT-rich diets and the role of chylomicrons: Our findings demonstrate that 
MCT-based diets promote allergic sensitization to simultaneously ingested antigens in an acute 
and a chronic feeding model. MCT-containing oils are regularly prescribed to patients with fat 
malabsorption or intestinal inflammation, and are added to some infant formulas and 
commercially available peanut butter (Eckhardt, Li, unpublished observations). The amounts of 
MCT required to promote peanut allergy remains to be determined, however. MCT, unlike LCT, 
do not form chylomicrons, which might protect from allergic sensitization. Chylomicron 
induction of macrophage cytokine production [188, 189], for example, may prevent Th2-biasing 
phenotypes in antigen-presenting cells (APC) and may, as suggested by our data, promote oral 
tolerance (Fig 2.3C). This is perhaps because of the high chylomicron content of retinol [190], 
which promotes oral tolerance by stimulating regulatory T-cell development [191-193]. 
Effect of MCT on Th2 cytokine expression in epithelial cells: The first cells to interact with dietary 
fatty acids are intestinal epithelial cells. These play a role in food allergies because of their 
barrier function, and of their active participation in immune responses to microbial and dietary 
antigens. One novel epithelial cytokine, TSLP, was recently shown to be important for the 
induction of experimental food allergy [170]. Interestingly, our studies showed that mice fed 
MCT via acute gavage or via dietary enrichment increase intestinal-epithelial expression of three 
Th2-biasing cytokines: TSLP, IL-25 and IL-33. This effect is greatest in the jejunum, which is the 
principal site of fat absorption. This may explain why MCT feeding also promoted antigen-driven 
IL-4 production and decreased IFN-J production by isolated splenocytes.  
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Chylomicrons and anaphylaxis: Besides their protective role in the sensitization phase of peanut 
and OVA allergy, chylomicrons were also protective in the effector phase of food allergy. Both in 
the peanut protein model and in a classical OVA model, gavage of the antigens with LCT did not 
cause anaphylaxis, unless PL81 was added. In contrast, gavage of antigens with MCT caused 
clinically significant anaphylaxis. This suggests that chylomicrons prevent the access of ingested 
antigens to mast cell- and basophil-associated IgE, and our in vitro basophil activation tests 
support this hypothesis in that the presence of chylomicrons greatly reduced the effect of OVA 
on basophils (Fig 2.7D) to an extent that would more than compensate for the increase in 
antigen absorption that is associated with chylomicron formation. We used Intralipid as proxy 
for chylomicrons, which are similar in size and lipid content but lack Apolipoprotein B48. 
However, they do acquire other apolipoproteins from serum [Robinson, 1979 #886] and show 
similar metabolic clearance rates [Bryan, 1976 #1361]. Nevertheless, we cannot exclude that 
other factors present on chylomicrons in vivo may differently affect mast cells or basophils. 
Moreover, whereas the inhibitory effect is significant, we do not know whether the effect is due 
to OVA sequestration by chylomicrons [Wang, 2009 #1171] or by an inhibitory effect on the 
basophils themselves. Our findings nevertheless suggest that postprandial lipid transport via the 
lamina propria in the upper GI tract, where most mast cells reside, or through the bloodstream, 
could have important effects on the effector phases of food allergies.  
Ingestion of antigen with water, rather than a fat, also failed to induce anaphylaxis. We currently 
cannot distinguish the possibility that antigen ingested with water is poorly absorbed from the 
possibilities that antigen ingested with water becomes associated with chylomicrons or is 
otherwise protected from access to mast cell and basophil IgE.  Regardless of the mechanism 
involved, our finding is still potentially relevant for optimization of oral desensitization, as 
currently attempted in small clinical trials [194]. Feeding antigen with LCT might prevent 
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anaphylaxis during oral treatment while boosting its effectiveness by promoting oral tolerance 
(Fig 2.2D).  
Concluding remarks: Our study suggests that dietary MCT may have a previously unappreciated 
effect on immune responses to dietary antigens, both on sensitization and anaphylaxis, by 
affecting antigen absorption and by promoting a Th2 bias. Although it is premature to vilify MCT, 
they nevertheless could be a novel dietary risk factor for allergies. In this respect, it is important 
to note that considerable MCT is present in breast- and infant formula. On the other hand, the 
Th2-biasing properties of MCT could be exploited to treat or prevent “Th1/Th17 diseases”, such 
as Crohn’s disease and diabetes. Interestingly, most of the effects of MCT could be mimicked by 
adding an inhibitor of chylomicron formation to LCT, which suggests that postprandial 
chylomicron formation plays an important role in immune responses to dietary antigens. This 
intriguing observation suggests that subtle genetic defects in the production, secretion, 
transport and clearance of chylomicrons may be a risk factor for food allergy development. 
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CHAPTER III. Dietary palmitic acid as a potential natural adjuvant in peanut allergy 
3.1 Introduction 
The prevalence of food allergies is rising, including allergies to peanuts, which is one of the more 
persistent and dangerous food allergies and results in numerous emergency room visits and 
approximately 200 deaths per year in the United States[28]. Peanut allergy is also increasing in 
countries with traditionally high peanut consumption, with dynamics that make it highly likely 
that environmental factors may contribute[195]. 
Several environmental factors may increase the risk for food- and other allergies, such as altered 
hygiene, lifestyle, and pollution. However, Western and westernizing societies have also 
undergone significant changes in their alimentation in a rather small time period, and it could be 
that some unsuspected dietary components increase the risk for allergic sensitization. Certain 
dietary components may affect the intestinal mucosal immune system and predispose it to 
develop inappropriate Th2 responses to dietary antigens. In a recent study at the role of one of 
the most common food components, fatty acids, we observed that mice can be made 
spontaneously allergic to peanut protein when force-fed a single dose of peanut butter protein 
in the presence of saturated medium-chain triglycerides (MCT) or when fed peanut protein for 
several weeks in the context of an MCT-rich diet[196]. This was associated with an effect of MCT 
on Th2 cytokine expression in the intestinal mucosa, including the cytokines Thymic Stromal 
Lymphopoietin (TSLP), IL-25, and IL-33. Other oils, such as soybean oil and peanut oil, did not 
appear to induce peanut allergy, unless an inhibitor of chylomicron formation was added. Since 
MCT, in contrast to the other oils, does not require chylomicron formation for its absorption by 
virtue of the short size of its fatty acids, we argued that postprandial chylomicron formation 
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protects from allergic sensitization, partially by affecting lymphatic absorption of dietary 
antigens[168, 196]. 
However, MCT also differs from soybean and peanut oil in the degree of saturation of its fatty 
acids. While refined MCT is virtually completely saturated, soybean and peanut oils are mainly 
unsaturated. We therefore wanted to test whether a mainly saturated oil with similar fatty-acid 
chain lengths as soybean- or peanut oil, and which is absorbed in a chylomicron-dependent 
manner, would also spontaneously cause allergic sensitization to peanut protein.  As a saturated 
fatty acids component in commercial vegetable oil, palmitic acid is predominantly esterified to 
the sn-1,3 positions of the triglyceride. It is reported that such palmitic-acid increases intestinal 
erosion and mucosal damage by failing to induce immunosuppressive regulatory T cells 
responses[197]. Our results show that palm oil significantly promotes spontaneous allergic 
sensitization to concomitantly ingested allergens, much like MCT. Therefore, chylomicron 
formation and fatty acyl saturation likely are independent risk factors for allergic sensitization. 
The physiological relevance of our findings are discussed. 
3.2 Materials and Methods 
3.2.1 Animals 
Male 5 week old C3H/HEJ mice were ordered from The Jackson Laboratory and were housed 
three per cage in a room of a specific pathogen-free animal facility with a 12h light / dark cycle. 
The mice were allowed to acclimatize for 1 week prior to experimentation. Unless indicated 
otherwise, the mice received standard rodent diet and filtered tap water ad libitum. All animals 
were handled in strict accordance with good animal practice as defined by the relevant national 
and local animal welfare bodies, and all animal work was approved by the Institutional Animal 
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Care and Use Committee of the University of Kentucky (Animal Welfare Assurance Number of 
the University of Kentucky A3336-01; U.K. IACUC protocol 2008-0306). 
3.2.2 Peanut extract preparation 
Jif-brand peanut butter (“To Go; Creamy”) was diluted with two volumes of MCT oil (Nestlé 
Nutrition) to reduce viscosity and then passed through a sieve with a 70 µm pore size to remove 
particles that would clog the gavage needle. The filtrate was then centrifuged (4 minutes; 
16,800xg) and the oily supernatant was completely removed and replaced with the respective 
experimentally used oils. The final volume of the suspensions equaled the initial volume of 
peanut butter. Triglycerides consisted of food grade palm- (Spectrum, PA105), peanut 
(Hollywood brand) or soybean (Kroger) oil. 
3.2.3 Effect of palm oil on acute allergic sensitization to peanut protein 
To determine whether palm oil promotes allergic sensitization to peanut protein, antigen naïve 
and fasted (4h) mice received a single 0.3 ml bolus of peanut butter protein in palm- or other 
oils via intragastric gavage with an 18G 38mm polypropylene feeding tube with rounded tip 
(Harvard Apparatus). The amount of protein per gavage was estimated to be around 80 mg 
using a Bicinchoninic acid (BCA) assay (Pierce). Mice were returned to their cages and kept for 
three more weeks on standard rodent diet before a blood sample was taken for anti-peanut IgE 
measurements.  
3.2.4 Effect of palmitate on jejunal epithelial TSLP mRNA expression 
Fasted mice were gavaged with 0.3 ml palm oil or peanut oil. After 5h, the mice were 
euthanatized and their jejuna were isolated and opened in cold PBS. Mucosal scrapings were 
collected and snap frozen for RNA isolation using the EZRNA kit from Omega-Biotech. RNA was 
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reverse-transcribed into cDNA with a Q-script kit from Quansys. The resulting cDNA was 
analyzed for abundance of TSLP relative to villin (which is restricted to the epithelium) with 
primer pairs ACG GAT GGG GCT AAC TTA CAA / AGT CCT CGA TTT GCT CGA ACT (TSLP) and TAA 
GGC TGC ACT CAA GCT GTA CCA/AGT CCT CAT GCT TGA GCA GGT CTT (villin; a marker chosen to 
normalize expression) using a Bio-Rad CFX-96 realtime PCR machine and SYBR Green-based PCR 
reagent.  
3.2.5 Effect fatty acids on epithelial TSLP expression in vitro  
Effects of fatty acids on TSLP expression in vitro were tested using CMT93 cells. This murine 
rectal epithelial line was obtained from American Type Culture Collection and cultured in an 
incubator at 37ºC, 100% humidity, and 5% atmospheric CO2 in HEPES- and bicarbonate-buffered 
DMEM/Ham's F12 medium supplemented with10% fetal calf serum (FCS) and antibiotics. 
Culture media and reagents were from Hyclone or Gibco. Cells were seeded in 12-well tissue 
culture plates, and when a confluent monolayer was obtained (usually within three days), the 
cells were washed with serum-free medium and incubated overnight with sodium salts of fatty 
acids (0.75 mM of either palmitic-, oleic-, or linoleic acid; highest purity available from Sigma) 
solubilized  with 0.5% fatty-acid-free bovine serum albumin (Sigma) in serum-free medium. After 
overnight incubation, medium was aspirated and RNA isolated and analyzed for TSLP expression 
as with jejunal mucosa, except that TSLP mRNA was normalized for GAPDH mRNA (primer pair 
CCA GGT TGT CTC CTG CGA CTT / CCT GTT GCT GTA GCC GTA TTC A) instead of villin. None of the 
treatments significantly affected cell viability as assessed with Trypan-Blue staining. 
3.2.6 Effect of palmitate on spontaneous allergic sensitization to peanut protein 
To study the effect of dietary triglycerides on allergic sensitization during longer-term feeding, 
male C3H/HeJ mice were fed for up to 6 weeks with custom diets in which 10% of the protein 
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source consisted of partially defatted peanut flour (the other 90% consisted of casein). The diets 
were prepared by Harlan Laboratories, Inc., using 12% dark-roasted peanut flour (Byrd Mill 
brand). As source of fat (20% of calories) served either palm oil (Harlan diet TD.110685) or 
peanut oil (Harlan diet TD.110684).  
3.2.7 Systemically allergen challenge 
 Three weeks after gavage with peanut protein or 4 weeks after chronic feeding of peanut 
protein in the various diets, mice received 30 mg of peanut butter protein intraperitoneally in 
0.3mL of sterile PBS [198]. Body temperature was measured telemetrically immediately before 
and every 5 minutes after the challenge, using subcutaneous transponders (Bio Medic Data 
Systems Inc.) and mast cell degranulation was estimated by measuring serum levels of mouse 
mast-cell protease 1 (mmcp-1) 90 minutes after the challenge by ELISA (eBioscience). Signs of 
anaphylaxis were estimated with a semi-quantitative scoring, with “0” being assigned to mice 
with no symptoms, “1” to mice which were stationary but moved when provoked, “2” to mice 
which remained immobile even when provoked, and “3” to mice which lied down. 
3.2.8 ELISA 
To detect antigen-specific IgE, we used a custom-developed ELISA as described before[196]. In 
short, 96 well BD Falcon ELISA plates were coated with 20 µg/100ul peanut butter protein in 
carbonate buffer (pH 9.6) at 4 ˚C overnight. Washed plates were then treated with blocking 
solution (NAP blocker, GBiosciences) for 1 h at room temperature. Mouse serum, diluted 1:10 in 
“NAP” blocking solution (GBiosciences), was added for 1 h at room temperature. Unbound 
ligand was washed with Tris-Buffered Saline containing Tween 20 (TBST). Alkaline-phosphatase 
conjugated goat anti-mouse IgE (SouthernBiotech) was added at 1:800 dilution in blocking 
solution and incubated for 60 min or longer at room temperature in complete darkness After 
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washing unbound antibody, AP substrate (femto-ELISA-AP Substrate; GBiosciences) was added 
and the absorption at 450 nm (A450) was read after addition of 50 µl stop solution (3 M NaOH).  
3.2.9 Statistics 
We used Graphpad Prism version 5 to analyze the results and the data were displayed as 
average ± S.E.M. One way ANOVAs were used for intergroup analysis following by between-
groups post-hoc analyses (Newman-Keuls). Temperature data were analyzed by comparing 
maximum temperature drop or area under the curve. Statistical significance was assumed at 
P<0.05. All figures show representative results of at least two repeats per experiment. 
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3.3 Results 
3.3.1 Gavage of peanut butter protein in palm oil induces allergic sensitization 
To test whether palm oil can promote oral allergic sensitization to peanut protein in a single 
gavage model similar as seen previously with MCT oil[196], we gavage fed male C3H/Hej mice 
with a single dose of 80 mg peanut protein in 0.3 ml of palm oil, peanut oil, or a 1:1 mixture of 
palm oil and peanut oil. Serum anti-peanut IgE was measured three weeks later. As shown in 
Figure 1A, mice that were gavaged with peanut protein in palm oil alone or palm oil mixed with 
peanut oil had significantly higher anti-peanut protein IgE than the mice gavaged with peanut 
protein in peanut oil only. Using soybean oil instead of peanut oil also did not result in 
significant allergic sensitization (Figure 3.1D). To test the anaphylaxis level of mice sensitized by 
gavage with peanut protein mixed with different oil, they were challenged intraperitoneally with 
30 mg peanut protein in 0.3 ml PBS to determine anaphylaxis. As shown in figure 3.1B and C, 
mice sensitized with peanut protein in palm oil alone or mixed 1:1 with peanut oil released more 
mmcp-1 into the bloodstream and showed a stronger drop in body temperature than mice 
sensitized by gavage with peanut protein in peanut oil only and water. While mice responding 
with a temperature drop and mmcp1 release showed clinical signs of anaphylaxis, such as 
immobility and hunched postures, diarrhea or significant stool softening was not evident as seen 
previously in experiments with MCT[196] (not shown). Similarly, Figure 3.1E and F showed the 
similar protective role of soybean oil as peanut oil in peanut protein sensitization and 
anaphylaxis. 
3.3.2 Feeding peanut flour in palm-oil based diets induces spontaneous allergic sensitization 
We previously reported spontaneous allergic sensitization in mice fed peanut-protein containing 
diets in which the fat source consisted of MCT (refined coconut oil). We tested whether palm-oil  
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Figure 3.1. Palm oil causes allergic sensitization and anaphylaxis. (A)&(D) Anti-peanut IgE 18 
days after gavage with peanut protein (80mg) in indicated vehicles (n=6). All the values are after 
control subtraction. (B)&(E) Body temperature drop after challenge by means of intraperitoneal 
injection 18 days after sensitization (30mg peanut protein in 0.3ml PBS). (C)&(F) Plasma mouse 
mast cell protease 1(mmcp-1) 90 minutes after the challenge. *P<0.05, **P<0.01, ***P<0.001. 
All the data are shown as mean±SEM. 
PA-Palmitic acid 
PO-Peanut oil 
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based diets would have similar effects, and observed indeed that mice fed with peanut flour in 
palm-oil based diets but not peanut-oil based diets developed anti-peanut protein IgE within 3-4 
weeks (Figure 3.2A). Consistent with this, we observed that the mice in the palm oil group, when 
challenged intraperitoneally with peanut protein in MCT as per our previous protocol[196], 
showed signs of anaphylaxis that were also reflected by increased serum mmcp1 levels (Figure 
3.2B). 
3.3.3 Palm oil induces jejunal TSLP expression 
Oral sensitization with dietary antigens may involve stimulation of intestinal epithelial 
expression of cytokines that promote Th2 responses, such as TSLP. To test whether the 
observed allergic sensitization with palm oil involved intestinal mucosal TSLP expression, we 
gavaged mice with palm oil or peanut oil (0.3 mL each) and isolated the jejuna 5h later. TSLP 
expression in mucosal scrapings was measured by RT-PCR and appeared to be significantly 
increased by palm oil compared with peanut oil or water. We next investigated whether palmitic 
acid, the major fatty acids derived from palm oil, is able to stimulate TSLP expression in vitro. To 
this end, CMT93 cells were incubated with PBS, palmitic, oleic-, or linoleic acid (as sodium salts; 
the major fatty acids in palm oil, peanut oil, and soybean oil, respectively), and TSLP mRNA was 
quantified by realtime PCR the day after. As shown in Figure 3.3B, palmitic acid significantly 
increased TSLP expression compared to the other fatty acids  Thus, it appears as if allergic 
sensitization through palm oil gavage is associated with upregulation of TSLP expression in the 
jejunum. 
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Figure 3.2. Effects of palm oil feeding on peanut sensitization and anaphylaxis. (A) Anti-peanut 
IgE during 4 weeks of feeding with diets enriched with peanut flour in which oil was replaced as 
indicated. (B) Plasma mouse mast cell protease 1(mmcp-1) 90 minutes after intraperitoneally 
challenge (30mg peanut protein in 0.3ml PBS). *P<0.05, **P<0.01, ***P<0.001. All the data are 
shown as mean±SEM.  
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Figure 3.3. Effects of palm oil intestinal epithelial TH2 cytokine expression in vivo and in vitro. 
(A) TSLP mRNA in epithelia from jejunum 4 hours after indicated vehicle gavage (n=6). (B) TSLP 
mRNA fold change in CMT93 cells 12hrs after incubating with 0.75mM of either palmitic-, oleic- 
or linoleic acid solubilized with 0.5% fatty-acid free bovine serum albumin in serum-free medium 
(n=3). *P<0.05, **P<0.01, ***P<0.001. All the data are shown as mean±SEM.  
  
72 
 
3.4 Discussion 
The main finding in this study is that acute or chronic palm oil feeding promoted allergic 
sensitization to concomitantly ingested antigens, as evidenced by increased antibody production 
and anaphylaxis following antigen re-exposure. This may be explained by our second finding 
that palmitate oil can induce the expression of novel Th2-biasing cytokines in the epithelium of 
the upper gastrointestinal tract. In the following, we will discuss each of these findings and 
address their potential relevance. 
Not only for cooking, palm oil existed broadly in the products around us such as body lotion, 
detergent, butter and other food products. Based on the evidence that Angiopoietin-like protein 
4 (Angptl4), an important modulator of LPL activity, can protect against severe proinflammatory 
effects characterized by severe mesenteric lymphadenitis of saturated fat  by inhibiting fatty 
acid uptake into macrophages in mesenteric lymph nodes[199], we believe saturated fatty acids 
have inflammatory effect on different tissues as refer to their pharmacological properties. 
Furthermore, Lu and his colleagues found that the palmitic-acid esterified to the sn-1,3 positions 
of the glycerol backbone, the main form of palmitic acid in vegetable oil, leads to intestinal 
erosions and morphological damage in Muc2-/- mice by failing to induce immunosuppressive 
regulatory T cells [197]. We previously demonstrated that acute or chronic MCT (medium chain 
triglycerides, which contains C8 and C10 mostly) feeding promoted allergic sensitization to 
concomitantly ingested antigens, as evidenced by increased antibody production and 
anaphylaxis following antigen re-exposure. The results were significantly different if we used LCT 
(long chain triglycerides, which contains mainly oleic and linoleic-acid.)[196]. MCT fatty acids 
that are from coconut oil are notably known as “saturated fatty acids”, this most likely gives us a 
hint of the different pharmacological properties on food allergy both in sensitization and 
anaphylaxis phases of saturated fatty acids and unsaturated ones. Interestingly, the palm oil we 
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used had much similar effects on promoting peanut protein allergy (Figure 3.1 and 3.2) as MCT 
that we reported. 
We then liked to investigate whether saturated fatty acids differ from unsaturated fatty acids in 
terms of immune responses to dietary antigen. The first cell barriers to interact with dietary 
fatty acids are the intestinal epithelial cells. It is now becoming increasingly clear that intestinal 
epithelial cells not only play a role in food allergies because of their barrier function, but also 
because of their active participation in immune responses to microbial and dietary antigens. 
TSLP, one novel epithelial cytokine was recently proved to be important for the induction of 
experimental food allergy[200]. Interestingly, our study showed that mice gavaged with palm oil 
had a significant increase in intestinal-epithelial expression of TSLP (Figure 3.3). The effect was 
biggest in the jejunum, which is the principal site of fat absorption. Then we got the same result 
in vitro when we used CMT 93 cells and different free fatty acids (Figure 3.3). 
In conclusion, our study suggests that dietary saturated fatty acids (Palm oil) may have a 
previously unappreciated effect on immune responses to dietary antigens, both on sensitization 
and anaphylaxis, by promoting a Th2 bias. Thus we have reasons to suspect the risk role of 
saturated fatty acids on some Th2 responses induced disease such as food allergy, pollen allergy, 
eczema and etc since Palm oil exists in a lot of daily necessities including baby products. This 
finding may explain why food allergy has regional properties. It also inspired us to expand our 
research targets to other saturated fatty acids to further prove our findings and to study TSLP 
involved JAK/STAT pathway. 
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CHAPTER IV. Materials and Methods of Chapter V and VI 
4.1 Animals and diets 
C57BL/6J (Stock #000664) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). 
Mice were housed individually ventilated cages with free access to food and water and 
maintained in a temperature-controlled room under negative pressure with a 14h/10h light:dark 
cycle. Mice homozygous for the ABCG5 and ABCG8 mutant alleles (G5G8 KO) and their WT 
littermates were obtained from trio breeding of male and female hemizygous mice as 
described[201]. G5G8 KO mice and their WT littermates were weaned between 18 and 21 days 
onto a pellet plant sterol free diet (PSF diet, Research Diet, D10040301) to prevent STSL[201]. 
Plasma levels of phytosterols were barely detectable compared with G5G8 KO mice on chow 
diet[202]. 
To induce STSL, G5G8 KO mice and their WT littermates were transferred to PSF diet after 
weaning for two weeks followed by standard chow diet for 10 weeks until the plasma levels of 
phytosterol reach steady statues (Figure 4.4A). 
Mice carrying the human CETP minigene (B6.CBA-Tg(CETP)5203Tall/J) were obtained from The 
Jackson Laboratory (Stock number: 003904). Mice were housed individually ventilated cages 
with free access to water and food. The colony was maintained in a temperature-controlled 
room under negative pressure with a 14h/10h light/dark cycle. Male hemizygous and female WT 
(C57BL/J) mice were bred by trio. Male CETP transgenic (Tg) and their WT littermates were 
weaned between 18 and 21 days onto standard rodent chow diet. 
To induce expression of transgene, mice analyzed between 10-12 weeks of age were transferred 
to high fat, high cholesterol Western diet (41% kcal fat, 1.5% w/w cholesterol, Research Diets 
Inc., New Brunswick, NJ. Product number: D12079B) for two weeks. 
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4.2 Plasma, bile and intestinal perfusate analysis 
Biliary and intestinal perfusate total cholesterol content were measured by commercial 
colorimetric-enzymatic assays (Wako Chemicals, Richmond, VA). Plasma phytosterol 
concentration was measured by GC-MS, using modifications of previously published 
methods[203]. Plasma CETP activity was determined by using commercial CETP activity assay kit 
(Roar CETP Activity Assay Kit, Cat. No. RB-CETP). Bile flow was determined gravimetrically 
assuming a density of 1 mg/mL. 
4.3 Intestine perfusion procedures 
Mice were anesthetized with 2mg urethane/g body weight intraperitoneally and placed in a 
temperature-controlled moist chamber (HUGO SACHS ELEKTRONIK HARVARD APPARATUS 
GmbH D79232, Germany) with steady temperature of 37°C to maintain body temperature. A 
longitudinal cut was made from the lower abdominal incision site along the midline to the 
sternum. Two hemostatic forceps were used to separate the skin and expose the peritoneum. A 
sterile cotton- tipped applicator wetted in sterile PBS was used to push aside the liver lobes and 
intestine to expose the common bile duct and gall bladder. The bile duct was ligated with a 3cm 
length silk suture and the gall bladder cannulated with a 10cm length of PE-tubing. The tubing 
was secured to the gall bladder with a 3cm length silk suture. Diverted bile was collected every 
10 or 15 minutes for 90 minutes and stored on ice. The tail vein was cannulated with a Tail Vein 
Catheter (Braintree Scientific, INC. No. MTV-01) attached to a syringe pump containing 20mM  
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Figure 4.1. Perfusion assay for measurement of biliary and intestinal cholesterol secretion 
rates simultaneously. 
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Figure 4.2. Bile acid content in mice bile and intestinal perfusate. The red dash line indicates 
the bile acids content in intestinal perfusate. Data were determined by two-tailed t-test. 
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tauracholate. Taurocholate was infused at a rate of 100nmol/min to maintain biliary lipid 
secretion. (Figure 4.1)  
Perfusion of the proximal (first 10 cm) small intestine where highest TICE rate was observed 
[132] were performed simultaneously. An inflow catheter attached to a peristaltic pump was 
inserted in the small intestine just below the fundus of stomach and an outflow catheter was 
fitted 10 cm distal to the inflow catheter for perfusate collection. Both catheters were fixed with 
intestine with 3cm length silk sutures. The proximal intestine was flushed with 5 mL PBS (37°C) 
to remove the lumenal contents and fill with perfusate (37°C, see fluid composition below). 
Perfusions were performed at a fixed flow rate (3 mL/h) over the 90 minute period. Perfusate 
fractions were collected every 10 or 15 minutes and stored on ice simultaneous to bile collection. 
At the end of the perfusion period, blood was collected by cardiac puncture and serum was 
obtained by means of centrifugation (12,000rpm, 2.5 min). (Figure 4.1) 
The rate of bile acid transit is 0.5 µmol/min and is similar to the rate of hepatic bile acid output 
(Figure 4.2) and allows for a comparison of the relative rates of biliary vs. intestinal cholesterol 
secretion. 
To examine HDL-mediated cholesterol delivery to bile vs. intestine, mice were injected with 
0.6µCi/mouse [3H]-cholesteryl oleate HDL retro-orbitally 30 minutes before the perfusion 
procedure.  
4.4 Perfusion fluid composition 
Perfusions were carried out with a modified Krebs solution (119.95 mmol/L NaCl, 4.8 mM KCl, 
1.2 mM KH2PO4, 1.2 mM MgSO4 · 7H2O, 15 mM HEPES, 1.3 mM CaCl2 · 2H2O and 10 mM L-
glutamine; final pH 7.4) supplemented with 10 mM bile salt and 2mM phospholipid (10 mM 
taurocholate [TC]: 2mM phosphatidylcholine [PC]). Mixtures were made as follows:  
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taurocholate (Sigma) was dissolved in methanol and egg yolk L-α-phosphatidylcholine (Sigma) 
was dissolved in chloroform. Two preparations were mixed in a volume ratio of 1:1 and solvents 
were evaporated under a mild stream of nitrogen at 45°C. The residue after evaporation was 
lyophilized overnight. Lyophilized samples were sealed and stored -80°C until the day of the 
intestine perfusions. Before the start of the intestine perfusions, the films were dissolved in 
perfusion buffer (room temperature).  
4.5 Mouse estrogen replacement treatment 
Ovariectomy was performed on WT female mice (C57BL/6, 8weeks age) and 2 weeks later these 
mice were assigned to groups to receive estradiol(E2, 0, 36, 200 or 600ug/ml, n=5 mice/group) 
via silastic tubing capsules for one month. A group of intact female mice (n=5) without drug 
treatment were included for control comparison. All of the surgery work was done by Dr. Lisa 
Cassis group, University of Kentucky. 
4.6 Immunoblot and Quantitative and Real-time PCR 
The preparations of proteins, SDS-PAGE, and immunoblotting were conducted as previously 
described[201]. STAT-60 (Tel-Test, Inc.) was used in total RNA extraction from liver and intestine 
and reversely transcripted into cDNA with iScript cDNA Synthesis Kit (BIO-RAD, Hercules, CA). 
The relative abundance was determined by RT-PCT using SYBR Green detector on Applied 
Biosystem 7900HT fast-Real Time PCR System (Carlsbad, CA)[201]. 
4.7 Isolation and labeling of lipoproteins 
Mouse HDL and human HDL (ρ = 1.063–1.21 g/ml) was isolated from fresh plasma from healthy 
human volunteers or male WT and CETP transgenic mice at age of 12 weeks by density gradient 
ultracentrifugation as described. All isolated fractions were dialyzed against 150 mM NaCl and 
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0.01% EDTA (saline-EDTA), and stored under nitrogen gas at 4°C. Protein concentrations were 
determined by the method of Lowry et al. HDL was labeled with 3H-Cholesteryl oleate as 
described previously[204]. Briefly, 3H-Cholesteryl oleate in acetone (15 μCi/mg protein) was 
added dropwise with swirling to 2 ml lipoprotein deficient serum (LPDS) in a glass tube at room 
temperature. The acetone was then evaporated under nitrogen gas for 45 min. 5 mg HDL in 2 ml 
saline-EDTA was added to the labelled LPDS and was incubated at 4°C for 2 h The density of the 
labelled lipoprotein was adjusted by solid KBr to 1.21 g/ml , then the labeled lipoprotein was 
recovered by ultracentrifugation for 11.5 h at 55000 rpm, dialyzed against saline-EDTA, and 
stored under nitrogen gas at 4°C. All procedures were performed under sterile conditions[205]. 
4.8 Statistical analysis 
All Data were presented as mean±S.E.M. and analyzed using GraphPad Prism. Data shown in 
were analyzed by two-tailed t-test, two-way ANOVA and linear regression. Significance was set 
at *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.  
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CHAPTER V. Sexually dimorphic adaptive responses maintain cholesterol elimination in the 
absence of ABCG5 and ABCG8 
5.1 Introduction 
ABCG5 and ABCG8 encode a pair of ATP-binding cassette half-transporters that form a complex 
(G5G8) promoting the elimination of neutral sterols and cholesterol[206] through hepatobiliary 
secretion. The expression of G5G8 is restricted in the liver and intestine. Mutations in either 
ACBG5 or ABCG8 result in sitosterolemia (STSL), a monogenic recessive disorder characterized 
by the accumulation of phytosterols in plasma, tendon, and tuberous xanthomas; elevated low 
density lipoprotein (LDL) cholesterol; and premature coronary artery disease[207]. Genetic 
ablation of G5G8 in mice disrupted cholesterol homeostasis[208], caused infertility and 
lipoatrophy[209], and liver abnormalities and cardiac lesions[210]. Disruption of both ABCG5 
and ABCG8 in mice leads to extremely low biliary cholesterol concentrations yet biliary 
phospholipids and bile acid concentrations are not altered[22].  Similar results are got from mice 
lacking either ABCG5 or ABCG8[21, 211]. Conversely, overexpression of ABCG5 and ABCG8 in 
mice leads to 5-fold increase in biliary cholesterol concentrations[23]. Besides, accelerating 
biliary cholesterol secretion by administration of adenoviral vectors encoding ABCG5 and ABCG8 
(AdG5G8) restores glycemic control and reduces plasma triglycerides in obese db/db mice[212]. 
It is also worth noting that G5G8-independent biliary cholesterol excretion has been found 
under some circumstances which needs further studies[213, 214]. 
With the exclusive function in cholesterol elimination, G5G8 plays a significant role in reverse 
cholesterol transport (RCT), the process consists of delivery of cholesterol from peripheral tissue 
and macrophages to liver, followed by secretion into bile by G5G8 and its final fecal elimination. 
This hepatobiliary pathway is considered to be the classic and sole route for cholesterol 
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secretion from body, playing a critical role in cardiovascular disease (CVD) prevention my 
mediating the cholesterol transferring to liver for disposal. However, it is found that some 
animal models which hepatic cholesterol metabolism were genetically altered still maintained 
certain amount of fecal neutral sterol levels[22, 128, 129, 141, 215, 216]. In ABCB4-/- mice with 
abrogated biliary phospholipid and cholesterol secretion that intravenously injected free 
cholesterol partly ended up in the feces as neutral sterol [128], suggesting a direct route from 
blood to intestinal lumen. This pathway was known as Transintestinal Cholesterol Excretion 
(TICE) [132], an important pathway for cholesterol elimination in mice. It was further proved 
that the cholesterol secreted into intestinal lumen originated from blood directly rather than 
intestine itself. Of importance of G5G8 in classic RCT, it is crucial to determine the role of G5G8 
in TICE. It was reported that the G5G8 KO still maintained certain amount of fecal neutral sterols 
loss[22]. Furthermore, when intestine perfusion was performed on G8 KO mice, no significant 
effect of lack of ABCG8 on cholesterol secretion from intestine was observed[132]. In another 
hand, in a mouse model with increased TICE induced by PPARδ agonist, intestinal G5G8 mRNA 
levels were found no significantly different[151]. Therefore, the role of G5G8 in TICE remains 
undetermined and needs further exploration. 
Like mentioned above, mutations in either ACBG5 or ABCG8 result in sitosterolemia (STSL) 
marked with elevated circulating phytosterol levels[208]. It was reported that circulating levels 
of sitosterol and campesterol are correlated with fractional and absolute absorption of dietary 
cholesterol positively, but are related to whole body cholesterol synthesis inversely. Therefore, 
accumulation of non-cholesterol sterols may account for the very low rates of cholesterol 
synthesis in STSL[217]. Yu et al. found there is approximately 50% decline in cholesterols in the 
livers and plasma of G5G8 KO mice due to low hepatic cholesterol synthesis relative to WT 
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mice[218]. Therefore, to better understand the role of G5G8 in RCT and TICE, it is necessary to 
exclude the effect of sitostrolemia.  
Among previous studies on cholesterol homeostasis such as biliary cholesterol secretion and 
transintestinal cholesterol efflux (TICE), male animals were the prevalent subjects to study on 
and gender differences were frequently neglected in the past. However, the rates of gallstone 
disease happen in women two to three times higher than men[219, 220]. One possible 
mechanism suggests that estrogen increases biliary cholesterol secretion causing cholesterol 
supersaturation of bile[221]. Besides, female mice expressed more ABCG5 and ABCG8 at mRNA 
levels stimulated by high cholesterol synthesis or dietary intake via LXRs[222] in the absence of 
cholesterol[223]. Therefore, it is rational to study cholesterol homeostasis on both genders. 
We speculated, on the basis of the above findings, that the role of G5G8 in TICE and whole body 
cholesterol homeostasis is underestimated due to the effects of STSL. It is also important to 
know the effect of STSL in whole body cholesterol homeostasis. Female and male mice were 
both used to study the sex-related difference in cholesterol elimination in this manuscript.  
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5.2 Results 
5.2.1 Female mice have higher biliary and lower intestinal total cholesterol secretion rates 
than male mice 
To determine if sex would affect the biliary and intestinal cholesterol secretion rates and the 
relationship between them, we use both male and female WT mice to perform perfusion assay 
described in Methods and Materials. Not surprisingly, we found the female mice had higher bile 
flow rates and bile cholesterol concentration than male mice (figure 5.1A&B). Similarly, we 
found higher biliary total cholesterol secretion rates in female mice than males in a time window 
of 90 minutes as expected (figure 5.1C&E). Interestingly, we found that female mice had lower 
intestinal total cholesterol secretion rates than male mice (figure 5.1D&F). Furthermore, It is 
worth noting that the sum of total cholesterol secreted from both hepatobiliary and 
transintestinal pathways remained similar in both genders (figure 5.1G). These data may suggest 
that female mice may prefer hepatobiliary pathways to eliminate cholesterol rather than 
transintestinal pathway compared with males. It also confirmed a complimentary relationship 
between hepatobiliary and transintestinal cholesterol secretion routes to maintain whole body 
cholesterol elimination that we found previously. 
5.2.2 Female mice adapt to G5G8 deficiency by increasing TICE 
To determine the impacts of G5G8 in TICE, we compared both biliary and intestinal cholesterol 
excretion rates in WT and G5G8 KO mice of both sexes. All mice were maintained on a PSF diet 
beginning at weaning to prevent the development of STSL. We found no differences on bile flow 
rate between either genotypes or sexes (figure 5.2A). No surprisingly, G5G8 KO mice had lower 
bile cholesterol concentration and biliary cholesterol excretion rates compared to their WT 
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littermates (figure 5.2B, C&E) as previously reported[201]. However, this difference is 
significantly  
 
Figure 5.1. Female mice have higher biliary and lower transintestinal cholesterol secretion 
rates than males. (A) Bile flow rate. (B) Biliary cholesterol concentration. (C-D) average biliary 
and intestinal cholesterol secretion rates. (E-F) Cumulative biliary and intestinal cholesterol 
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secretion rates. (G) Sum of cholesterol secretion. ****p<0.0001. Data were analyzed by T test 
(upper) and linear regression (bottom). All data are shown as mean±SEM. 
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greater in females compared with males (figure 5.2B, C &F). The differences of biliary 
cholesterol concentration we found in male mice between genotypes were not as prominent as 
what was reported before[224]. The possible reason might be the effect of plant sterol in the 
diet that would inhibit cholesterol synthesis[208] that our experimental mice did not have 
access to yet was ingested by the mouse model used previously. Interestingly, intestinal total 
cholesterol excretion was increased in female KO mice compared with their WT littermates, 
indicating a possible G5G8 independent cholesterol elimination. The difference not observed in 
males (figure 5.2D, G&H). Besides, no differences of the genes implicated in RCT were found 
different between genotypes (figure 5.3). It is worth noting that NPC2 expressions are high in 
females than males in both liver and intestines in both genotypes (figure 5.3). 
5.2.3 G5G8 KO male mice showed pronounced decrease in biliary cholesterol secretion when 
fed with PS containing diet (chow diet) 
G5G8 KO male mice have about 90% lower biliary cholesterol levels compared to their WT 
littermates fed with chow diet[201]. We found that G5G8 KO mice had lower bile cholesterol 
concentration and biliary cholesterol excretion rates compared to their WT littermates yet this 
difference is significantly greater in females compared with males fed with PSF diet (figure 5.2B, 
C &F). To check if the plant sterol is the factor that affect the cholesterol secretion in G5G8 KO 
mice, we transferred male G5G8 KO mice and their WT littermates from PSF diet back to chow 
diet and monitor the development of STSL. About 10 weeks later, the plasma plant sterol levels 
of G5G8 KO mice reached a steady state and were more than 120-fold than WT littermates 
(figure 5.4A). Perfusion assay was performed on these mice and we detected more pronounced 
difference in biliary cholesterol secretion rates between G5G8 KO and WT mice (figure 5.4B) 
than what was found in mice fed with PSF diet (figure 5.2F). When maintained on chow diet, 
accumulation of non-cholesterol sterols may lead to the very low rates of cholesterol synthesis  
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Figure 5.2. Female mice adapt to G5G8 deficiency by increasing TICE. (A) Bile flow rates. (B) 
Biliary cholesterol concentration. (C-D) average biliary and transintestinal cholesterol secretion 
rates of G5G8 KO mice and WT mice in both sexes during surgery. (E-F) Cumulative biliary 
cholesterol secretion of G5G8 KO and WT mice in both sexes during 90 minutes. (G-H) 
Cumulative intestinal cholesterol secretion of G5G8 KO and WT mice in both sexes during 90 
minutes surgery. ****p<0.0001. Data were analyzed by two way ANOVA (upper) and linear 
regression (middle and bottom). All data are shown as mean±SEM. 
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Figure 5.3. Relative mRNA expression in the livers and intestines. mRNA expressions were 
determined by real-time PCR. n=4~5 per group. Data were analyzed by two-way ANOVA. 
***p<0.001, ****p<0.0001 
90 
 
in STSL[225] and that may accounts for the low cholesterol levels in bile of G5G8 KO mice fed 
with PS containing diet. This result also indicated that the exclusive role of G5G8 in biliary 
cholesterol secretion in male mice may be overestimated.  
5.2.4 Estrogen can manipulate G5G8 expression in female mice 
To determine the possible mechanism accounts for the greater dependence on hepatobiliary 
cholesterol secretion in female mice, we test liver G5G8 protein and mRNA levels of both sexes 
and female mice underwent estrogen replacement treatments. Ovariectomy was performed on 
WT female mice (C57BL/6, 8weeks age) and 2 weeks later these mice were assigned to groups 
to receive estradiol(E2, 0, 36, 200 or 600ug/ml, n=5 mice/group) via silastic tubing capsules for 
one month. A group of intact female mice (n=5) without drug treatment were included for 
control comparison. As expected, we found bare G5G8 expression in G5G8 KO mice in both 
sexes. And we also found that in WT groups, females had much more G5G8 expressions in the 
livers than males (figure 5.5A), which is consistent with the finding that female tend to secrete 
more cholesterol into bile than males[221]. Accordingly, we found E2 treatment upregulated 
liver ABCG5 expressions compared to intact control mice (figure 5.5B) that may explain why 
females express more G5 than males. Interestingly, the G5G8 mRNA expressions of livers were 
the opposite of their protein levels (figure 5.5C&D). There might be a post-translational protein 
manipulation mechanism that needs to be further determined.  
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Figure 5.4. Biliary cholesterol secretion rate was recovered in male ABCG5/G8 KO mice when 
transferred back to chow diet for 10 weeks. (A) plasma plant sterol levels of male WT and G5G8 
KO mice three weeks after transferring to chow diet. (B)  Cumulative biliary cholesterol 
secretion of WT and G5G8 KO mice during 90 minutes. ****p<0.0001. Data were analyzed T test 
(left) and linear regression (right). All data are shown as mean±SEM. 
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Figure 5.5. Estrogen upregulate ABCG5 expression in mRNA levels in the livers. (A-B) Western 
blot of ABCG5 and SR-B1 protein levels in livers of ovariectomized female mice treated with 
different doses of estrogen. (C-D) Relative mRNA expression for livers of ovariectomized female 
mice treated with different doses of estrogen. Data were analyzed by T test. All data are shown 
as mean±SEM. *p<0.05, **p<0.01, ***p<0.001.  
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5.3 Discussion 
We made several findings within the present study: 1) Female mice preferentially eliminate 
cholesterol through the biliary pathway, whereas male mice depend on intestine. 2) Estrogen 
increases G5G8 that may account for this difference. 3) Female mice adapt to G5G8 deficiency 
by increasing TICE. 4) In the absence of sitosterolemia, male G5G8 KO mice maintain biliary 
cholesterol secretion with an unknown mechanism.  
TICE is a specific pathway that accounts for up to 70% of daily total body neutral sterol secretion 
in mice[140]. However, the possible transporters that accounts for cholesterol delivery to 
intestinal lumen remains unknown. The sterol efflux proteins ABCG5/ABCG8 seem to be good 
candidates for the mediation of cholesterol secretion from enterocytes to the intestinal lumen. 
However, many studies disagree on the relevance of G5G8 to TICE[132, 151, 208], making its role 
unclear.  
However, there are three points that are worth noting in the previous studies. Firstly, male mice 
are the most prevalent subjects in cholesterol homeostasis and TICE studies, and gender 
differences were frequently neglected in the past. However, the rate of gallstone disease in 
women is two to three times higher than in men[219, 220], due to the cholesterol supersaturation 
of bile[221] caused by increased biliary cholesterol secretions. In addition, female mice express 
much more ABCG5 and ABCG8 at mRNA levels, stimulated by high cholesterol synthesis or 
dietary intake in the absence of cholesterol[223]. We also found that female mice express more 
G5 protein in livers than male mice fed with a PSF diet (figure 5.5A). It is rational to research 
cholesterol homeostasis in both sexes. Secondly, in previous TICE studies, intestinal perfusion 
assays were widely used to measure the average rate of transintestinal cholesterol secretion. In 
some of the studies, bile was cannulated for 15 minutes to measure the basal bile flow and the 
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cholesterol concentration, yet hepatobiliary cholesterol secretion rates were not measured at 
the same time as TICE[137, 151]. We developed an assay that allowed us to compare the 
relationship between the rates of hepatobiliary and transintestinal cholesterol secretion and 
how they cooperate in whole body cholesterol homeostasis. Lastly, mutations in either ACBG5 
or ABCG8 result in STSL marked with elevated circulating phytosterol levels[208] and 
accumulation of non-cholesterol sterols may account for the very low rates of cholesterol 
synthesis in STSL[217]. Most of the previous studies were based on G5G8 KO mice fed with a 
chow diet. It is important to understand the role of G5G8 in cholesterol homeostasis exclusive of 
STSL. In our experiment, we measured and compared both biliary and intestinal cholesterol 
secretion rates on G5G8 KO mice and their WT littermates in both sexes. These mice were 
maintained on PSF diet to prevent STSL after weaning. Thus, we can determine the effects of sex 
and STSL on the cholesterol elimination process. 
Not surprisingly, we found that female mice had high biliary cholesterol concentration and 
secretion rates than male mice (figure 5.1), which is consistent with the phenomenon that 
females tend to secrete more cholesterol into bile than males[221]. Furthermore, females 
express higher G5 in the liver than male mice, and estrogen upregulated the G5 expression in 
female mice livers (figure 5.5A). In addition to estrogen induced biliary cholesterol saturation, 
these results may also explain why patients of any gender who underwent hormone 
replacement therapy tend to have increased risk for gallstone formation[221]. But we did not 
find a consistent expression of G5G8 at mRNA levels (figure 5.5B). There might exist a 
posttranslational mechanism that accounts for it. However, the female mice had lower total 
cholesterol secretion rates in the intestine than male mice (figure 5.1D&F), and the sum of the 
total cholesterol secreted from both hepatobiliary and transintestinal pathways remained 
similar in both sexes (figure 5.1G). This data suggests that female mice defaults hepatobiliary 
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pathways to eliminate cholesterol, rather than transintestinal pathways as compared with males. 
The results also confirmed a complimentary relationship between hepatobiliary and 
transintestinal cholesterol secretion routes to maintain whole body cholesterol elimination, a 
finding that posited in another study.  
As expected, we found that G5G8 KO mice have lower cholesterol concentration than WT mice 
in both sexes, a finding which was widely reported (figure 5.2B&C). However, this difference is 
significantly greater in females compared with males (figure 5.2B, C &F). The differences in male 
mice between genotypes were not as prominent as what was reported before[224], which 
means that the G5G8 KO mice maintained a certain level of biliary cholesterol secretion in the 
absence of plant sterol. These mice were maintained on a PSF diet, thus explaining the plant 
sterol’s effects on cholesterol secretion that our experimental mice did not have access to, 
unlike the previous models. Based on the mechanism that was mentioned in the second 
paragraph, it is very likely that blockage of cholesterol synthesis induced by accumulation of 
plant sterol made the role of G5G8 in RCT overestimated. Furthermore, deficiency in plant sterol 
may stimulate some possible G5G8 independent pathways in male G5G8 KO mice for biliary 
cholesterol elimination.  
In addition, we found that the total cholesterol excretion in the intestine was increased in 
female KO mice compared with their WT littermates, indicating another possible G5G8 
independent cholesterol elimination pathway. Two possible G5G8 independent cholesterol 
elimination pathways were reported before. Annemiek Groen at el. reported that the ATP8B1 
deficient mice maintained a high cholesterol output as WT mice did independent of G5G8 
activity. The possible cause for this phenotype is due to the direct extraction of cholesterol from 
the canalicular membrane by hydrophobic bile salts caused by an ATP8B1 deficiency[214].  
Donna at el. reported a G5G8 independent mechanism for basal biliary cholesterol secretion in 
96 
 
rats during lactation, but a dependence on G5G8 for maximal biliary cholesterol secretion[213]. 
The possible transporter responsible for increased TICE in female G5G8 KO mice needs to be 
further explored. 
 In summary, the present studies demonstrate sexually dimorphic cholesterol elimination in 
mice. Female mice preferentially eliminate cholesterol through the biliary pathway, whereas 
males depend on the small intestine with the possible mechanism that estrogen increases G5G8 
expression in the liver. Female mice adapt to G5G8 deficiency by increasing TICE by an unknown 
G5G8 independent cholesterol elimination mechanism. In the absence of STSL, male G5G8 KO 
mice maintain biliary cholesterol secretion by an unknown mechanism, and the role of G5G8 
may be overestimated in mice with STSL. 
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CHAPTER VI. CETP alters route of total and HDL cholesterol elimination 
6.1 Introduction 
Cardiovascular disease (CVD) is the leading cause of death globally and account for approximate 
one-third of all deaths in the United States[226].  Plasma concentration of LDLc is thought to be 
one of the primary predictors of CVD incidence and lowering LDLc has been the primary 
therapeutic target for preventing and treating CVD for decades [226]. However, CVD-associated 
mortality and morbidity were not reduced prominently with LDLc lowering with statin therapy 
[227], HDLc elevating therapy has become the promising therapeutic target because HDLc was 
shown to be the even more relevant predictor than LDLc for CVD in a great amount population 
studies [100]. HDLc’s cardioprotective role was explained by many mechanisms, but functioning 
in facilitating Reverse Cholesterol Transport (RCT) is widely accepted. 
The classic RCT pathway starts from the efflux of cholesterol from peripheral tissues and from 
macrophages in the arterial wall through the cholesterol transporter adenosine triphosphate-
binding cassette transporter ABCG1 and ABCA1 [228, 229]. The cholesterol carried by 
lipoproteins is transported to the liver for uptake by the specific receptors SR-BI on the 
hepatocyte surface. HDL, although some findings on transgenic mice indicate that LDL was also 
involved [124], is widely accepted as the main lipoprotein that mediates this process. The 
cholesterol is transferred to bile through canalicular membrane of hepatocyte after uptake at 
the basolaterol side by cholesterol transporter ABCG5 and ABCG8[22]. Biliary cholesterol is 
secreted to intestinal lumen where a certain amount of reabsorption of cholesterol occurred 
[230]. Remaining of cholesterol is eliminated through feces. 
This hepatobiliary pathway is considered to be the classic and only route for cholesterol 
secretion from body. However, it is found that some animal models which hepatic cholesterol 
98 
 
metabolism were genetically altered still maintained certain amount of fecal neutral sterol levels 
[22, 128, 129, 141, 215, 216]. It was reported that in ABCB4-/- mice with abrogated biliary 
phospholipid and cholesterol secretion that intravenously injected free cholesterol partly ended 
up in the feces as neutral sterol [128], suggesting a direct route from blood to intestinal lumen. 
This pathway was known as Transintestinal Cholesterol Excretion (TICE) [132], an important 
pathway for cholesterol elimination in mice. It was further proved that the cholesterol secreted 
into intestinal lumen originated from blood directly rather than intestine itself. Which 
lipoproteins are involved in this transport remains controversial. Several receptors mediate 
hepatic uptake of cholesterol from circulating lipoproteins for cholesterol elimination. Scavenger 
receptor B1 (SR-B1) preferentially binds to ApoA1 and mediates the uptake of esterified 
cholesterol mainly from HDL [134]. Unexpectedly, TICE was increased about two-fold in SR-B1-
deficient mice [137]. Similarly, ABCA1-/- mice that lack normal HDL content secreted 
radiolabeled cholesterol from plasma into intestinal lumen at a similar rate as WT mice did and 
TICE was unaltered between two mice models [140]. Low density lipoprotein receptor (LDLR) 
plays an important role in the classic hepatobiliary route and clears apolipoprotein (apo)B-
containing LDL particles or apoE lipoproteins [231]. However, contrary to liver, Cédric Le May at 
el. found that the acute repression of TICE was dependent on the LDLR yet LDLR-/- mice tended 
to have increased TICE [139].  Thus the findings on the lipoproteins contributed to TICE remains 
unclear and needs to be explored. 
Cholesteryl ester transfer protein (CETP) is a 74kDa glycoprotein to transfer cholesteryl ester 
from HDL to larger lipoprotein like LDL or VLDL, and to exchange triglyceride from larger 
lipoproteins to HDL concomitantly [232]. CETP transgenic mouse strains have shown higher 
cholesterol levels of VLDL and LDL and lower levels of HDL than normal WT mice [233]. In this 
study, we investigated the roles of different lipoproteins in TICE by using CETP transgenic mouse 
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model with varied plasma lipoprotein pools. We also evaluated the role of HDL in TICE by 
injecting tritium labeled HDL particles to mice of two genotypes. Data indicated that CETP 
enhanced hepatobiliary cholesterol secretion in mice yet which was not contributed by HDL. In 
contrast, CETP modified HDL particles favored TICE for cholesterol elimination. 
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6.2 Results 
6.2.1 CETP had no effects on physiological features and plasma lipoprotein profile in mice 
maintained on Rodent Chow Diet 
To define if CETP changed physiological features on mice under basal conditions, male WT and 
CETP Tg mice were transferred to Rodent Chow Diet after weaning until 12 weeks for 
experimental use. As expected, we found that the plasma CETP activity was barely detected in 
WT mice, but was much abundant in transgenic mice and was comparable to what is in human 
plasma (Figure 6.1B). Interestingly, body weight and plasma cholesterol concentration seemed 
not affected by this and did not differ between two genotypes (Figure 6.1 A&C). Similarly, FPLC 
analysis did not show plasma lipoprotein distribution differences between genotypes (Figure 
6.1D). CETP genes facilitates the transport of cholesteryl esters and triglycerides between 
lipoproteins in plasma. The inefficiency of CETP in transgenic mice fed with Rodent Chow Diet 
may be due to the lacking of sufficient triglycerides pool as substrates for CETP to work with in 
these mice. 
6.2.2 CETP had no effects on either biliary or transintestinal total cholesterol secretion rates 
in mice maintained on Rodent Chow Diet 
To determine if CETP has effects on biliary and tranintestinal cholesterol secretion rates under 
basal conditions, we performed perfusion assays described in Materials and Methods on male 
CETP and WT mice at age of 12 weeks to compare biliary and transintestinal cholesterol 
secretion rates simultaneously. We found that CETP does not affect bile flow rates and bile 
cholesterol concentrations in mice maintained on Rodent Chow Diet (Figure 6.2A&B). Similarly, 
we did not detect a difference on biliary and transintestinal cholesterol secretion rates in a 
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period of 90 minutes between genotypes either (Figure 6.2C-F). Interestingly, compared to the 
relative  
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Figure 6.1. CETP had no effects on mice body weights, plasma cholesterol concentration and 
plasma lipoprotein distribution in mice fed with Rodent Chow diet. (A) Mice body weights, (B) 
plasma CETP activity, (C) cholesterol concentration and (D) FPLC fractions analysis of 12-week 
male WT and CETP transgenic (Tg) mice fed with rodent chow diet.  n=3~4 per genotype. Data 
are mean ± S.E.M. Panel (A-C) were determined by two-tailed t-test. ****p<0.0001 
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low biliary cholesterol secretion rates (Figure 6.2E), both genotypes performed a compensatory 
increased intestinal cholesterol secretion rates (Figure 6.2F). But when cholesterol secretion 
rates were compared within genotypes, we found that the both male WT and CETP mice favored 
intestine to eliminate cholesterol when maintained on chow diet (Figure 6.8A&B). (Female mice 
were the opposite, unpublished data) Furthermore, the sum of total cholesterol secreted from 
both hepatobiliary and transintestinal pathways remain similar in both genotypes (Figure 6.8C). 
These data may suggest a complimentary relationship between hepatobiliary and transintestinal 
cholesterol secretion routes to maintain whole body cholesterol elimination.  
6.2.3 CETP upregulated mice body weights, liver weights and plasma cholesterol levels and 
altered HDL and LDL cholesterol contents predominantly in response to two-week high 
fat, high cholesterol Western Diet feeding 
It is known that cholesterol upregulates CETP activity and hepatic CETP gene expression in 
transgenic mice expressing human CETP, and high fat content diet further enhance this effect 
[234]. To make the physiological features of CETP transgenic mice more prominent, 8 weeks 
CETP transgenic mice and WT littermates were transferred to high fat, high cholesterol Western 
Diet for two weeks. As expected, CETP activity was predominantly elevated by 2 weeks Western 
Diet feeding (Figure 6.3B). Different from mice fed with Rodent Chow Diet, the body weights 
and plasma cholesterol levels were higher in CETP transgenic groups compared to WT controls 
accordingly (Figure 6.3A & C).  Furthermore, CETP predominantly reduced HDL and elevated LDL 
content according to mice plasma FPLC analysis (Figure 6.3D). 
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Figure 6.2.  CETP had no effects on either biliary or transintestinal total cholesterol secretion 
rate in mice fed with rodent chow diet. (A) average bile flow rates, (B) Biliary cholesterol 
concentration, (C) average biliary cholesterol secretion rates and (D) average transintestinal 
cholesterol secretion rates of male WT and Tg mice at age of 12 weeks in a period of 90 minutes. 
(E) Cumulative biliary cholesterol secretion rates and (F) Cumulative intestinal cholesterol 
secretion rates of 12 weeks male WT and Tg mice throughout 90 minutes. n=3 per genotype. 
Data are mean ± S.E.M. Panel (A-D) were determined by two-tailed t-test. Panel (E&F) were 
determined by linear regression. P value less than 0.05 is considered to be significant. 
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Figure 6.3.  Tg mice had higher mice body weights, plasma cholesterol concentration and had 
altered plasma lipoprotein distribution in response to two weeks western diet feeding. Mice 
body weights (A), Plasma CETP activity (B), cholesterol concentration (C) and FPLC fractions 
analysis (D) of 12-week male WT and Tg mice fed with Western Diet for two weeks.  n=6 per 
genotype. Data are means ± S.E.M. Panel (A-C) were determined by two-tailed t-test. *p<0.05, 
**p<0.01, ****p<0.0001 
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6.2.4 CETP altered hepatobiliary and transintestinal total cholesterol secretion rates in mice 
maintained on Western Diet for two weeks 
Similar as described above, we performed perfusion assay on 12-week male mice maintained on 
Western diet for two weeks. Bile total cholesterol concentrations, but not bile flow rates of CETP 
group were higher compared to WT mice (Figure 6.4A&B), which indicated both increased 
average and cumulative biliary cholesterol secretion rates in a period of 90 minutes (Figure 
6.4C&E). In contrast, CETP mice showed a decreased intestinal total cholesterol secretion rates 
compared to WT group (Figure 6.4D&F). Similarly, when cholesterol secretion rates were 
compared within genotypes, we found that when maintained on Western Diet, WT mice did not 
have differences between biliary and intestinal total cholesterol secretion rates yet CETP mice 
had much lower intestinal cholesterol secretion rates compared to their biliary pathway (Figure 
6.9A&B). Interestingly, when cumulative biliary and intestinal cholesterol secretion rates were 
added up, there were no differences between two genotypes on sum of cholesterol secretion 
rates (Figure 6.9C). Combine with the results in mice fed with chow diet, this results may further 
illustrate that the hepatobiliary and intestinal cholesterol secretion routes are compensatory to 
each other in cholesterol elimination independent of genotype. Furthermore, CETP may 
facilitate cholesterol to hepatobiliary route for elimination when stimulated by Western Diet. 
Most of genes involved in cholesterol homeostasis were not found significantly different 
between genotypes in both liver and intestine (figure 6.5). 
6.2.5 CETP altered hepatobiliary and transintestinal HDL-derived cholesterol secretion rates in 
mice fed with Western Diet for two weeks 
By knowing that CETP would alter hepatobiliary and transintestinal total cholesterol secretion 
rates when stimulated with Western Diet, we next want to illustrate if this alteration was due to  
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Figure 6.4.  CETP upregulated biliary and downregulated intestinal total cholesterol secretion 
rates in mice fed with western diet for two weeks. Unlike bulk cholesterol secretion, HDL-
derived cholesterol were preferentially delivered to the intestine in Tg mice. (A) average bile 
flow rates, (B) Bile cholesterol concentration, (C) average biliary cholesterol secretion rates and 
(D) average intestinal cholesterol secretion rates throughout 90 minute. (E) Cumulative biliary 
cholesterol secretion rates and (F) transintestinal cholesterol secretion rates throughout 90 
minutes. n=6 per genotype. Data are means ± S.E.M. Panel (A-D) were determined by two-tailed 
t-test. Panel (E&F) were determined by linear regression. *p<0.05, **p<0.01, ****p<0.0001. 
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Figure 6.5. Gene expression in both protein levels and mRNA levels in liver and intestines of 
WT and CETP transgenic mice. (A) Western blot of ABCG5 and SR-B1 protein levels in livers of 
WT and CETP transgenic mice. (B) Relative mRNA expression of genes for livers of WT and CETP 
transgenic mice. (C) Relative mRNA expression of genes for intestines of WT and CETP transgenic 
mice. Data were analyzed by T test. All data are shown as mean±SEM. *p<0.05. 
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the different routes that lipoprotein-derived cholesterol went through in the presence of CETP. 
In another study, we injected 12 weeks male CETP and WT mice fed with both Rodent Chow and 
Western Diet with 0.6µCi/mouse [3H]HDL-cholesterol ester retro-orbitally 30 minutes before 
perfusion assay. Similar to total cholesterol secretion patterns, when maintained on Chow diet, 
CETP has no effects on HDL-derived cholesterol secretion rates from both routes (Figure 
6.6A&B). Interestingly, we found that HDL-C secretion patterns of both biliary and intestinal 
routes were the opposite to total cholesterol secretion rates when the mice were fed with 
Western Diet for two weeks. CETP mice showed decreased hepatobiliary and increased 
intestinal HDL-C secretion rates compared to WT controls (Figure 6.6C&D). These results suggest 
that under Western Diet feeding condition, HDL-derived cholesteryl esters were preferentially 
delivered to the intestinal lumen directly rather than bile in CETP transgenic mice for cholesterol 
elimination. Therefore, the increased bulk biliary cholesterol secretion rates we observed in 
CETP Tg mice were not mainly contributed by HDL. 
6.2.6 CETP-modified HDL favored intestine for cholesterol elimination 
It was reported that treatment with CETP may delay the clearance of rat HDL cholesteryl ester 
from blood and its uptake by the liver[235]. This finding may explain why HDL-derived 
cholesteryl ester in CETP mice preferentially delivered to the intestinal lumen directly rather 
than bile for cholesterol elimination. To further explore if CETP-modified HDL altered the 
pathway for HDL-derived cholesteryl ester elimination, we extracted and labeled HDLs from 
both 12 weeks WT and CETP male mice maintained on western diet for two weeks with [3H]-
cholesteryl ester. 0.6µLCi/mouse labeled WT and CETP HDLs were injected back to two groups 
of male WT mice retro-orbitally respectively 30 minutes before perfusion assay. We did not 
detect differences between biliary WT HDL and CETP HDL derived cholesterol secretion rates 
(Figure 6.7A), which is consistent to what was reported [235]. However, intestinal CETP HDL-C 
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secretion rates were higher than that of WT HDL-C, which indicated that CETP modified HDL 
preferentially delivered cholesterol to intestine for cholesterol elimination (Figure 6.7B). 
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Figure 6.6. CETP altered hepatobiliary and intestinal HDL-derived cholesterol secretion rates in 
mice fed with Western Diet but not Chow Diet. 0.6 µCi/mouse of human [3H]-cholesteryl 
oleate HDL was injected into 12 weeks male WT mice 30 minutes before surgery. (A) 
cumulative biliary [3H]-cholesterol secretion rates in mice fed with chow diet. (B) cumulative 
intestinal [3H]-cholesterol secretion rates in mice fed with chow diet. (C) cumulative biliary [3H]-
cholesterol secretion rates in mice fed with Western Diet. (D) cumulative intestinal [3H]-
cholesterol secretion rates in mice fed with Western Diet.  n=4~5 per genotype. Data are 
means±SEM. Data were analyzed by linear regression.  ****p<0.0001. 
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Figure 6.7. CETP-modified HDL favored intestine for cholesterol elimination. 0.6 µCi/mouse of 
[3H]-cholesteryl oleate HDL extracted from WT and Tg mice fed with Western Diet for two 
weeks was injected into 12 weeks male WT mice 30 minutes before surgery. (A) Cumulative 
biliary [3H]-cholesterol secretion rates. (B) Cumulative intestinal [3H]- cholesterol secretion rates. 
n=6 per genotype. Data are means±SEM. Data were analyzed by linear regression.  *p<0.05. 
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Figure 6.8. Both Tg and WT mice have higher intestinal than biliary total cholesterol secretion 
rates when maintained on chow diet. (A) Cumulative total cholesterol secretion rates in WT 
mice. (B) Cumulative total cholesterol secretion rates in Tg mice. (C) Sum of biliary and intestinal 
total cholesterol secretion rates in both genotypes. n=3 per genotype. Data are means±SEM. 
Data were analyzed by linear regression.  **p<0.01.  
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Figure 6.9. Tg but not WT mice had higher biliary than intestinal total cholesterol secretion 
rates in response to two-week Western Diet feeding. (A) Cumulative total cholesterol secretion 
rates in WT mice. (B) Cumulative total cholesterol secretion rates in Tg mice. (C) Sum of biliary 
and intestinal total cholesterol secretion rates in both genotypes. n=5~6 per genotype. Data are 
means±SEM. Data were analyzed by linear regression.  ****p<0.0001. 
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6.3 Discussion 
We made several findings within the present study: 1) CETP upregulated biliary and 
downregulated intestinal total cholesterol secretion rates. 2) HDL-derived cholesterol ester in 
CETP transgenic mice favored the intestine for cholesterol elimination. This can be explained by 
the fact that CETP-modified HDL favored intestine for cholesterol elimination. 3) Active 
cholesterol secretion pathways in both liver and intestine appear to work corporately to 
maintain cholesterol excretion routes. 
Firstly, we reported a method for simultaneous measurement of intestinal and biliary 
cholesterol secretion for at least 90 minutes to compare cholesterol elimination rates between 
hepatobiliary and transintestinal pathways. In previous TICE studies, intestinal perfusion assays 
were widely used to measure the average rate of transintestinal cholesterol secretion. In some 
of the studies, bile was cannulated for 15 minutes to measure the basal bile flow and cholesterol 
concentration, yet hepatobiliary cholesterol secretion rates were not measured at the same 
time with TICE[137, 151]. We developed an assay that allowed us to compare the relationship 
between the rates of hepatobiliary and transintestinal cholesterol secretion. During intestine 
perfusion, we ligated the bile duct and cannulated gall bladder for bile collection in 90 minutes 
period. Because the intestine is the main site for bile salt reabsorption, the bile duct ligation in 
the classic intestine perfusion assay cut off the enterohepatic circulation of bile salts and other 
non-lipid components found in bile. As amphipathic molecules with hydrophobic and hydrophilic 
regions, conjugated bile salts function as cholesterol acceptor in cholesterol secretion process 
[236]. To solve the bile salts exhaustion issue during the assay, we infused the mice with 
taurocholate through the tail vein to supplement exogenous bile salts to maintain normal biliary 
cholesterol secretion. To mimic the rate of physiological bile acids secretion to the intestinal 
lumen, the bile acid amount in the intestinal perfusate we used was at the similar range of what 
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is in the real bile (Figure 6.10). Thus, this assay allows us to compare the hepatobiliary and 
transintestinal cholesterol secretion rates simultaneously so that we can have an idea of the 
potential relationship between the two pathways and how they cooperate in whole body 
cholesterol homeostasis. 
TICE is a specific pathway that accounts for up to 70% of daily total body neutral sterol secretion 
in mice[140]. However, the possible lipoproteins that deliver cholesterol to this pathway remain 
controversial. It was reported that HDL does not mediate TICE based on the evidence that 
ABCA1-/- mice did not show altered TICE rates as compared to WT mice[140]. Furthermore, TICE 
increased about two-fold in SR-B1-deficient mice[137]. However, contrary to the liver, Cédric Le 
May at el. found that the acute repression of TICE was dependent on the LDLR when PCSK9 was 
present, yet LDLR-/- mice tended to have increased TICE[139]. Thus, the extent on the 
lipoproteins contributed to TICE remains unclear and needs to be explored. Mice lack CETPs and 
have much lower biliary cholesterol relative to bile salt secretion as compared with 
humans[237]. CETP transgenic mice overcame the issue and humanized the biliary lipid 
secretion. CETP transgenic mouse strains have shown altered plasma lipoprotein pool 
composition[233], and plasma CETP activity can be further stimulated by high fat diet (Figure 
5.3D). Therefore, CETP transgenic mice are proper models to study the role of the contributions 
of different lipoproteins to TICE.  
In the first study, we did not see many differences in physiological features of CETP transgenic 
mice fed with chow diet, following no difference in both hepatobiliary and transintestinal 
cholesterol secretion rates as compared with WT mice (Figure 6.1&6.2). Although CETPs were 
highly expressed in the plasma of transgenic mice, HDLs are still the main components in the 
plasma lipoprotein pool[232]. Indeed, studies with the human hepatoma cell line HepG2 show 
that the efficiency of CETP on the uptake of HDL cholesteryl ester is high only in the presence of 
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LDL[238]. Therefore, the results we saw from mice fed with chow diet may be due to the lack of 
a certain amount of proper substrate (LDL) and triglycerides pool (Figure 6.1D) for CETP to work 
with. Secondly, LDLR is ubiquitously expressed in mammals and plays an important role in 
maintaining cholesterol homeostasis[239]. LDLR recognizes ApoB-100 of LDL particles through a 
stoichiometry of a single copy of apoB-100 per one LDL particle per receptor monomer[239]. 
The low content of plasma LDL might be due to the efficiency of LDLR uptake in transgenic mice.  
It is known that cholesterol upregulates CETP activity and hepatic CETP gene expression in 
transgenic mice expressing human CETP, and a high fat content diet further enhances this effect 
[234]. We found that the CETP transgenic mice had lowered HDLs and increased LDLs and other 
altered prominent physiological features when stimulated with a 2-week Western Diet feeding 
(Figure 6.3). Under this condition, CETP transgenic mice showed increased biliary total 
cholesterol secretion rates and decreased transintestinal cholesterol secretion rates compared 
to WT mice (Figure 6.4). This result might be explained by the different favored pathways of 
lipoproteins for cholesterol elimination as a result of the various lipoprotein pools that the two 
groups of mice have (Figure 6.3D). Interestingly, if the cholesterol secretion amount from both 
biliary and transintestinal pathways were added up, the total cholesterol secretion rates 
remained the same between two genotypes (figure 6.8). This result indicated that both liver and 
intestine active cholesterol secretion pathways appear to work corporately to maintain the 
cholesterol excretion route. This finding is consistent with many reports that the patients or 
mammals which experienced deficiency in normal biliary cholesterol secretion maintained 
normal levels of fecal neutral sterol[128, 130]. This finding further illustrates the importance of 
the intestine as a potential therapeutic target for cholesterol elimination when this function of 
the liver is deficient.  
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However, it is still not clear if the increased biliary and decreased transintestinal cholesterol 
secretion rates in CETP transgenic mice were caused by the increased plasma LDL content in 
transgenic mice. Compared to LDLs, HDLs are still the main components of the lipoprotein pool 
in the plasma of transgenic mice (Figure 6.3D). Next, human HDLs labeled with 3H-Cholesteryl 
oleate were used to determine the role of HDL in biliary and transintestinal cholesterol secretion 
pathways. Interestingly, we found decreased biliary and increased transintestinal HDL-derived 
cholesterol (HDL-C) secretion rates in CETP transgenic mice, which are in contrast to the total 
cholesterol secretion rate trends (Figure 6C&D). According to this result, it is likely that HDL-C 
did not contribute to the increased biliary cholesterol secretion rates as much as to the 
transintestinal ones. Additionally, this result is consistent with the finding that the HDL features 
were modified by CETP and hepatic uptake of HDL-ester is delayed after treatment with CETP in 
rats[235]. Therefore, we hypothesized that HDL from transgenic mice was modified by the 
plasma CETP and favored the intestine rather than the liver for cholesterol elimination. HDL 
from both WT and transgenic mice (untreated HDL and CETP modified HDL) were collected and 
labeled with 3H-cholesteryl oleate and injected back into WT mice retro-orbitally to track their 
elimination pathways. We found no differences in biliary HDL-C secretion rates from two 
treatments (Figure 6.7A), which is in agreement with the finding that the biliary HDL-C secretion 
was not different between CETP-treated and untreated HDL administration in rats[235]. Not 
surprisingly, the mice had higher transintestinal CETP modified-HDL-C secretion rates as 
compared to untreated HDL-C (Figure 6.7B). This is consistent with our previous finding that HDL 
favored the intestine for cholesterol elimination in transgenic mice (Figure 6.6D). We can 
assume that some remodeling took place on HDLs in the plasma which affected their uptake by 
liver and intestine. 
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The findings showed that CETPs upregulated biliary and downregulated intestinal cholesterol 
secretion rates, but HDL-derived cholesterol ester favored intestine for cholesterol elimination 
in CETP transgenic mice. This can be explained by the fact that CETP-modified HDL favored 
intestine for cholesterol elimination. More importantly, the perfusion assay we developed 
allowed us to compare the biliary and intestinal cholesterol secretion rates simultaneously, by 
which the relationship between the two pathways were studied for the first time. Both liver and 
intestine active cholesterol secretion pathways appear to work corporately to maintain 
cholesterol excretion routes. 
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CHAPTER VII. Summary and General Discussion for chapter II and III 
7.1 Summary 
The purpose of this study is to determine the hypothesis that fatty acids with different 
chain lengths and saturabilities affect allergic sensitization and anaphylaxis. We demonstrated 
that the absorption pathways of food allergens are varied by absorbing together with different 
fatty acids, leading to different sensitization and anaphylaxis statues. Our findings demonstrated 
that MCT diets promote allergic sensitization to ingested antigen in both acute and chronic 
feeding model whereas LCT played a suppressive role. Similarly, this result can be repeated 
when a chylomicron inhibitor, PL-81, when added to LCT. Unlike LCT, MCT do not form 
chylomicrons that might play a protective role in allergen sensitization and anaphylaxis phases. 
Formation of chylomicron induces macrophage cytokine production that may prevent Th2-
biasing phenotypes in antigen-presenting cells (APC) and may promote oral tolerance. Instead of 
processing antigen into chylomicrons, we found that MCT promote antigens into Peyer’s 
Patches, in particular, the local dendritic cells, more compared to LCT. The role of Peyer’s 
Patches in food allergy is unclear although some studies suggested their roles in oral 
tolerance[240, 241]. Interestingly, LCT promote antigen to Peyer’s Patches more than MLN, 
despite less than MCT. This result may be explained by the possibility that chylomicrons traffic 
through the MLN but prevent the uptake or processing of associated antigens by MLN dendritic 
cells. Besides the protective role in sensitization phase, chylomicron formation also plays a 
suppressive role in anaphylaxis phase of food allergy. Gavage of antigen with LCT in sensitized 
mice did not cause anaphylaxis, unless PL81 was added. In contrast, gavage of MCT in sensitized 
mice caused clinically significant anaphylaxis. The possible explanation is that chylomicrons 
prevent the access of ingested antigens to IgE associated with mast cells and basophils. This 
121 
 
hypothesis is proved by in vitro basophil activation tests that the presence of chylomicrons 
reduced the effects of antigen on basophils significantly. 
Besides the effects on antigen absorption pathway, LCT and MCT have different 
pharmacological effects on intestinal epithelial cells, which play important roles in food allergy 
because of their barrier function and active participation in immune responses to microbial and 
dietary antigens like mentioned in section 1.1.2.. We found that MCT via acute gavage or via 
chronic dietary enrichment increased intestinal-epithelial expressions of three Th-2 biasing 
cytokines: TSLP, IL-25 and IL-33, among which, TSLP was shown to be important for the 
induction of experimental food allergy11. The effect is greatest in the jejunum, the major site for 
fat absorption. This may explain why MCT exacerbate food allergy in both sensitization and 
anaphylaxis phases in another way. MCT is one type of saturated fatty acids. Likewise, we found 
that other saturated fatty acids have the similar effects on intestinal epithelial cells. We found 
that acute palmitate oil feeding promoted allergic sensitization to concomitantly ingested 
antigens, as evidenced by increased antibody production and anaphylaxis following antigen re-
exposure. This result may also be explained by the finding that palmitate oil can induce the 
same Th-2 biasing cytokines in the intestinal epithelium, which was confirmed by our in vitro 
experiment. 
In conclusion, our study suggested that MCT may have a previously unappreciated effect 
on immune responses to dietary antigens, both on sensitization and anaphylaxis, by affecting 
antigen absorption and by promoting a Th2 bias. Other saturated fatty acids have similar effects 
as MCT due to the pharmacological effects on intestinal epithelial cells. 
7.2 Insights of effects of fatty acids on food allergy and role of MCT 
7.2.1 The importance of altering antigen absorption pathway by fatty acids 
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Our diet contains great amount of potentially antigenic proteins. Most of those proteins 
are going through enzymatically degradation, yet a small fraction of them escape from the 
degradation and enter body through largely unclear mechanisms. In healthy individuals, the 
escaped allergen (small amount) usually leads to systemic immunological tolerance (“oral 
tolerance”). However, in sensitized individuals, these allergens absorption usually cause 
significant morbidity such as celiac disease or food allergies. Apparently, two questions coming 
from this phenomenon become interesting and important: What happen after escaped allergens 
were absorbed? Is this process the key step to determine the immune system to go to direction 
of oral tolerance or allergy? Our findings that LCT play a protective and suppressive role and 
MCT play an exacerbated role in both sensitization and anaphylaxis phases successesfully 
answer the first question, which is the first time to propose the idea that other dietary 
components other than food antigen itself, fatty acids with different chain lengths, determine 
the induction of food allergy through altering the absorptions of food antigens. Like mentioned 
in 1.2.2, MCT is absorbed into the portal circulation, passing through the liver and then 
immediately into systemic circulation. In contrast, LCT is absorbed via chylomicron formation 
and enters lymph circulation first and then systemic circulation, suggesting that LCT spend 
approximately 4 hours in contact with mesenteric immune system before reaching the systemic 
circulation through the thoracic duct[242]. Based on that, our finding that MCT, instead of LCT, 
decreases systemic allergen absorption but increased Peyer’s Patches absorption and IgE 
formation establishes a foundation for the future researches on locating where the antigens are 
“seen” by APC and how they “choose” to induce Th1 or Th2-bias immune responses. Besides, 
this is also a further confirmation for our previous finding[168]. 
7.2.2 Pharmaceutical effects of fatty acids on intestinal epithelial cells- from the angle of 
evolution of physiological system 
123 
 
Our findings of the pharmacological effects of fatty acids on intestinal epithelial cells 
also illustrate the importance of fatty acids in food allergy induction. MCT and other saturated 
fatty acids such as palmitate oil induce production of Th2 cytokines in intestinal epithelial cells, 
which put the individuals and animals in a “ready state” for being sensitized when food antigen 
is present. Besides, fatty acids released in large amounts from dietary triglycerides in the upper 
gastro-intestinal tract have potent detergent properties and may induce transient mucosal 
inflammation, damage and gut leakiness[74] which, theoretically, would allow ingested soluble 
food antigens to enter the body. It was reported that in mice lacking Angptl4, a lipoprotein 
lipase inhibitor, saturated fat induces a severe phenotype characterized by fibrinopurulent 
peritonitis, ascites, intestinal fibrosis, and cachexia[80], which further demonstrated the 
inflammatory effect of fatty acids itself on intestinal epithelial cells. These findings led to an 
important concerning about food industrialization. It has been said, “Nothing in biology makes 
sense except in the light of evolution”[243]. In that light, the digestive, metabolic, and immune 
systems of humans and animals have evolved over millions of years and would be affected by 
the sudden changes in the energy source. Only around 600 years ago, most of human 
population was still living in hunter-gathered societies and consuming the “Paleolithic diet”[244]. 
However, the current Western diet contains most of the calories from seeds, dairy products, 
refined plant oils and refined sugar[244]. None of which were available and consumed during 
the majority of human evolution. The mechanical processing of foods has occurred from around 
100 years ago and greatly accelerated in the last 50 to 60 years. This phenomenon probably 
induce the inadaptation of the physical system that experienced slowly evolution, thus leading 
to some new emerging diet-induced diseases. 
Instead of the human evolutionary diet, in which foods were consumed whole, the 
vegetable-derived cooking oils are separated from seeds, nuts and other plants by mechanical 
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extraction or screw-press or by organic solvent extraction[245]. The intake of such oils has 
increased in the past century, and exponentially since 1950, to more than 50 lb per person 
yearly (figure 7.1[245]). It is worth noting the negative effects of solid hydrogenated (to make 
the oil more stable due to the improvement of saturability) trans-fatty acids. About 25% of 
dietary essential fatty acids are not intake as refined oils rather than in whole foods. Simply 
speaking, corn oil does not equal corn and olive oil does not mean olives[245]. Therefore, the 
pro-inflammatory effects of oil on intestinal epithelial cells are likely due to the food processing 
rather than food itself. As to peanut products, peanut butter consumption has dramatically 
increased since 1950 as well, with the average child in the U.S. eating 1500 peanut butter 
sandwiches through high school. A study from 30 years ago reported that fecal fat excretion 
decreased when changing from ingesting whole peanuts to an equal weight of peanut butter, 
suggesting the peanut butter consumption result in a hyperabsorption of fat[246]. Combined 
with our findings, the role of fatty acids in food allergy induction appears to be more significant 
when consuming peanut products instead of whole peanuts. Another example is baby food. 
MCT is easier to be digested and absorbed compared to LCT and is the main component of fat 
(60%) in breast milk during lactating, based on which, MCT is also used as the majority fat 
source in baby formula processing. However, different from formula, breastmilk is a mixed 
supply of both nutrients and immune protection in terms of the immunoglobulin A levels. 
Besides, very small amount of food antigens would transfer from mom to babies which possibly 
induce oral tolerance to protect the baby instead of being sensitized. According to our finding, 
lactating is very likely the key time window for induction of certain food allergy in babies which 
may become their lifelong burden. That’s to say, without immune protection, consumption of 
MCT only is likely the reason for some babies to induce development of certain food allergy 
which may last the whole life. More evidences need to be provided to test this hypothesis. 
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7.3 The insight of MCT oral sensitization mice model 
7.3.1 Significance of the model in food allergy studies 
In researches of food allergy, several strains including C3H/HeJ, BALB/c mice have be 
investigated as murine animal models for food allergy[247]38. These animals have more 
capacities to produce the anaphylactic antibodies such as IgE and/or IgG1 than others, and 
strains can be divided into high or low IgE responders39. One of the most challenging obstacles 
is to develop murine model of ORALLY induced food allergy due to the tendency for the immune 
system to develop oral tolerance to ingested antigens[248]. We have the similar find that the 
gavage mice with combination of peanut protein and water would not induce sensitization. 
Several rodent models have been developed by using distinct sensitization routes, such as 
intraperitoneal[248, 249] or subcutaneous[250, 251] injection of allergen or genetically modified 
bacteria expressing food antigens[252]. Apparently, these models have several limitations that 
they do not reflect the pathogenic mechanism that induces food allergy, and thus could 
underestimate the importance and involvement of mucosal immune system. With the regard, 
the ideal food allergy rodent model should mimic human food allergy by inducing food 
hypersensitivity by oral ingestion. To achieve this goal, it is necessary to bypass the tendency of 
mice to develop oral tolerance and to ensure the induction of a Th2 response by antigen after 
administration. It is found that toxins such as cholera toxin (CT) have the capability to orally 
stimulate Th2 response and the production of IgG1 antibodies[253, 254]. Recently, other 
bacterial toxins such as staphylococcal enterotoxin B[255] or some approaches based on anti-
acid treatment[256, 257] are developed as well. However, these orally sensitization models still 
have drawbacks. The adjuvants of toxins are used to disrupt the tolerogenic potential of the oral 
route which could underestimade the natural Th2 immune response by food antigen and which 
cannot truly reflect how individuals are sensitized by food antigen in the daily lives. Based on the 
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food allergy models, our finding that MCT, a common dietary fatty acids, would induce 
sensitization successfully without intentionally disruption of tolerogenic potential of immune 
system, which is an oral food allergy model that is truly reflect how Th2 response is induced by 
food antigen itself and is the model most close to the induction of human food allergy by pure 
food components. 
7.3.2 Significance of the model in development of oral vaccination 
The idea of “sensitization” is the similar idea as “vaccination”, the purpose of both of 
which are to generate great amount of antibodies with stimulation of proteins or peptides. As 
early as 900 years ago, the bedousin of the negev desert were reported to feed a dog-bitten 
person the liver of a rabid dog to cure rabies for several days. In ancient China, physicians there 
prescribed the medicines made from fleas collected from sick cows to prevent smallpox. With 
full evidences, in 1900, the Nobel laureate, Charles Richet, demonstrated that the raw meat 
feeding can cure tuberculous dogs which he termed as zomotherapy[258]. Today, most of the 
vaccines are administered by injection with limitations that recipients especially children hate 
needles. In the current times, there are very few licensed oral vaccines and more candidates are 
under development[258]. Based on that, our MCT oral sensitization model may provide a new 
insight of developing oral vaccination by using food-borne component only. 
7.4 Experimental limitations 
 We recognize that our studies have some limitations. In study of protective role of 
chylomicron in effector phase of food allergy, we did an in vitro experiment using intralipid as a 
substitute of chylomicrons. The emulsions contain particles with similar size and lipid content as 
chylomicron but lack Apolipoprotein B48 although intralipid particles would acquire other 
apolipoproteins from serum [259] and have similar metabolic clearance rates as 
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chylomicrons[260]. Using chylomicron separated from mice as carrier might be more relevant to 
physiological conditions. 
Secondly, in the same experiment, we did not determine if the inhibition effect on 
activation of basophils is due to chylomicron particles or their sequestration function for 
antigens. Nevertheless, we demonstrated from this experiment that postprandial lipid transport 
via lamina propria has important effects on the effector phases of food allergies. 
We also found that ingestion of antigen with water rather than fat fail to induce 
anaphylaxis. We currently cannot distinguish the possibility that antigen ingested with water is 
poorly absorbed from the possibilities that antigen ingested with water becomes associated 
with chylomicrons or is otherwise protected from access to mast cell and basophil IgE. 
Regardless of the mechanism involved, our finding is still potentially relevant for optimization of 
oral desensitization, as currently attempted in small clinical trials[261].  
7.5 Clinical implications 
Besides the significance on food industrialization discussed in 7.2 and on development 
of oral vaccination discussed in 7.3, our finding that feeding antigen with LCT might prevent 
anaphylaxis can be an alternative approach during oral treatment while boosting its 
effectiveness by promoting oral tolerance. Please refer to 1.2.1.3 for the introduction of clinical 
treatment on food allergy by inducing oral tolerance. 
7.6 Future directions 
7.6.1 Peyer’s Patches role in food allergy induction 
Peyer’s patches have been studies as a major site for mucosal IgA responses yet less in 
oral tolerance. The results of present study provide direct evidence for the role of Peyer’s 
patches in the induction of oral tolerance. It was reported that ovalbumin (OVA) transgenic mice 
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had significant increase in transgenic T cells in Peyer’s Patches of mice tolerized by OVA, 
indicating the importance of Peyer’s patches in the development of oral tolerance[262, 263]. 
Peyer’s patches were also found essential for the induction of systemic hyporesponsiveness to 
ingested antigen. We found that both LCT and MCT promote antigen to Peyer patches more 
than MLN, among which MCT would enhance the effect more. It is well accepted that APC, such 
as dendritic cells, macrophages and MHC II B cells, play major roles in the induction of mucosal 
immune responses. Therefore, it is worth determining the role of functioning immune cells in 
Peyer’s patches and how they direct the immune response to oral tolerance or sensitization 
responses. 
7.6.2 Studies on chylomicrons and anaphylaxis 
Chylomicrons are large, spherical triacylglycerol-rich lipoproteins which surface is 
covered with phospholipid monolayer and contains free cholesterol surrounded by a large 
protein, apoB48. Besides, several exchangeable apolipoproteins can be found on the surface of 
the chylomicron, in cluding apoAI, apoAIV, and apoCs. Like discussed in 2.4, to investigate the 
role of chylomicron in shielding epitopes of food antigen, it is more closed to physiological 
conditions by using chylomicrons separated from animals for the in vitro experiments. 
Secondly, chylomicron assembly begins with apoB48 translation. The insufficient supply 
of lipids or microsomal triglyceride transfer protein (MTP) induce degradation of the nascent 
polypeptide. MTP can interact with and transfer lipids to the nascent apoB physically[264]. With 
help from MTP, apoB fold into a configuration which can accept more lipids[265]. Therefore, 
MPT plays an important role in assembly and secretion of chylomicrons. To know better about 
the role of chylomicrons in sensitization and anaphylaxis phases, MTP deficient mice model will 
be good approach to study on. 
7.6.3 Mechanism studies by using TSLP deficient mouse model 
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As discussed in 2.3, the effects of MCT and saturated fatty acids on intestinal epithelial 
cells include stimulating expression of Th2 bias cytokines, TSLP and IL-33 in particular. TSLP and 
IL-33 are critical cytokines responding at the interface between the environment and the body 
with local and systemic immune responses, most of which are thought to be Th2 type[266]. 
Mast cells are distributed everywhere and particularly abundant in epidermis, epithelial cells 
and endothelial cells where TSLP and IL-33 are produced most. Besides, mast cells respond to IL-
33 and TSLP rapidly due to the high expression of the receptors like ST2[267]. In addition, TSLP 
and IL-33 affect other cell biology of mast cells such as growth, development and attachment 
which affect the inflammatory response and probably of significant for the pathology of 
different diseases that is regulated by IL-33/TSLP-mast cell link. To better understand the 
hypothesized link of MCT/Saturated FA-TSLP/IL-33-mast cell-sensitization, TSLP deficient mice 
are worth using by determining the effects of MCT and saturated FA on induction of 
sensitization in this mice model. 
CHAPTER VIII: Summary and discussion for chapter IV and V 
8.1 Summary 
In this study, we want to determine the role of cholesterol transporter ABCG5/G8 in 
TICE and the possible cholesterol donors in TICE based on CETP transgenic mice models. 
In the first study, we found a sexually dimorphic cholesterol elimination in mice that 
females have higher biliary cholesterol concentration and biliary cholesterol secretion rate but a 
lower intestinal cholesterol secretion rates than male mice. This finding suggested that female 
mice preferentially eliminate cholesterol through biliary pathway where male mice depend on 
intestine. Our finding is consistent with the clinical phenomenon that females tend to secrete 
more cholesterol into bile than males[221]. Furthermore, we confirmed that female mice have 
more liver ABCG5 protein expression than male mice fed with PSF diet, which might explain the 
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result above from the angle of cholesterol secretion. Interestingly, the sum of total cholesterol 
secreted from both biliary and transintestinal pathways, suggesting a complimentary 
relationship between these two pathways. Secondly, we found that the differences of biliary 
cholesterol levels between WT and G5G8 KO mice were greater in females than in males when 
fed with PSF diet. The difference between genotypes in male mice was recovered when 
transferred to chow diet (plant sterol-containing diet). These data suggest that accumulation of 
plant sterol may be partially responsible for the blockage of cholesterol secretion in G5G8 KO 
mice due to its effect of inhibiting cholesterol synthesis[217]. Simultaneously, we found that 
female KO mice have increased transtintestinal cholesterol secretion rate compared to their WT 
littermates, indicating a possible G5G8 independent cholesterol elimination. However, the 
possible transporter responsible for that need to be further explored. 
In the second study, we used CETP transgenic mice as models which have altered 
plasma lipoprotein profile to determine the role of HDL in TICE. When fed with western diet, we 
found that CETP mice had increased biliary total cholesterol secretion rates and decreased 
transintestinal cholesterol secretion rates compared to WT mice. This result might be explained 
by the different favors of different lipoproteins for cholesterol elimination. In addition, we also 
found the same result that sum of total cholesterol secreted from biliary and transintestinal 
pathways were the same between genotypes, which further confirmed out finding in the first 
study that these two pathways work corporately with each other for cholesterol elimination. 
Secondly, we found that HDLs did not contribute to increased biliary cholesterol secretion rate 
as much as TICE. This result may be explained by the finding that uptake of CETP modified HDL 
was delayed in the rats[235]. We next collected and labeled HDLs from both WT and CETP mice 
and injected them back to WT mice retro-orbitally to track their elimination pathways. We 
found that mice had higher transintestinal CETP modified HDL-C secretion rates compared to 
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untreated HDL-C and we did not detect any difference of those in bile. We assumed that some 
remodeling took place on HDL in the plasma that affect their uptake by liver and intestine. 
In conclusion, we found sexually dimorphic cholesterol elimination in mice and 
ABCG5/G8 independent cholesterol secretion pathway in female TICE and male biliary pathway 
when fed with PSF diet. Plant sterol is the possible factor to affect biliary cholesterol secretion 
rate in ABCG5/8 KO mice. Based on CETP transgenic model, we found that CETP transgenic mice 
have higher biliary cholesterol secretion rate, which is not contributed by HDL. Furthermore, 
HDL modified by CETP may favor intestine for cholesterol elimination. 
8.2 Cross-talk between liver and intestine on cholesterol metabolism 
In our studies on TICE, the most prominent finding is that no matter that either biliary or 
transintestinal cholesterol secretion pathway was altered, the sum amount of cholesterol 
secreted from both pathways remained similar, which happened in almost all of our mice model 
such as between female and male mice, WT and G5G8 KO mice and between WT and CETP 
transgenic mice. These findings suggested that liver and intestine work corporately with each 
other on cholesterol elimination, illustrating and further confirming the cross-talk between liver 
and intestine on cholesterol metabolism. 
As discussed in 1.3.2, the liver controls plasma cholesterol levels via a complete 
metabolic network of a series of lipoprotein receptors, sterol transporters and nuclear receptors, 
which can translates the signals by cholesterol levels alteration into transcriptional regulation of 
gene expression. Among these factors, LDLR, SR-B1, LXR- and SREBP-targeted pathways that 
functioning significant this network have been extensively reviewed[239, 268-271]. Linked to 
liver by bile duct, the intestine, which is the main site for cholesterol absorption and excretion, 
is important in regulation of cholesterol metabolism (see 1.1.3). Therefore, it is important to 
point out that the balance of cholesterol uptake, synthesis and excretion requires extensive 
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cross-talk between liver and intestine.  It is known from chapter 1.3.2 that RCT is delivery of 
cholesterol from peripheral cells or macrophages to the liver and eliminated in feces from the 
body. After uptake by liver, some cholesterol is used to synthesis of BS through the process of 
addition of a hydroxyl group on position 7 of the steroid nucleus by the enzyme CYP7A1 as 
neutral sterols or bile acids (BS). Intestine would absorb certain amount of cholesterol and BS 
that is secreted into intestinal lumen as described in 1.1.3. It is interesting that the complete 
absence of cholesterol absorption does not have any symptoms. However, the absence of 
intestinal bile can cause deficiencies of essential lipids, leading to clinical symptoms such as 
increased fecal fat loss, malnutrition and a retardation of growth and development in 
children[272]. Therefore, the conversion of cholesterol to BS have considerable significances. 
For one thing, BS is one of the major route for sterol removal from the body and is the 
important cholesterol acceptor for cholesterol transport assistance. Another thing is that BS 
have been found to play an important role in signal transduction pathways. 
8.2.1 BS and signaling 
BS may play a role in regulation of energy homeostasis through the activation of nuclear 
bile acid receptor FXR[273, 274] and the membrane-bound G-protein coupled receptor 
TGR5[274]. In the recent years, it has become clear that BS are not only the major constitution 
of bile and facilitation of dietary fats absorption, but also involved in energy metabolism in both 
genomic and non-genomic ways. BS are the natural ligands of FXR, which regulate BS synthesis 
and transport downstream genes within enterhepatic circulation directly, or by induction of 
FGF15/19 in intestinal epithelial cells. FGF15 and FXR are indicated in control of energy 
metabolism. Furthermore, BS signal through another pathway in peripheral tissues and 
intestinal L cells involving activation of TGR5, which is reported to stimulate energy expenditure 
in brown adipose tissue and skeleton muscle. In colon, TGR5 activation stimulate GLP-1 
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secretion from L-cells which promotes pancreatic insulin secretion, thus improves hepatic and 
peripheral insulin sensitivity[275]. 
8.2.2 BS and cholesterol 
The connection between cholesterol and BS metabolism including some other 
important processes are manifold. It is believed in the literature that BS excretion reflects the 
main route for cholesterol removal from the body. However, in other species including humans, 
this opinion is not quite true. It was reported the ratio of fecal neutral sterol/BS excretion of 2:1 
in humans[276-279] and closer to 1 in rodents yet with largely variations between strains and 
depending on different experimental conditions[280]. It is demonstrated that fecal BS loss 
contributes to cholesterol turnover significantly due to the physiological functions related to the 
amphiphatic nature of the BS molecules, but 95% of BS showed up in the intestinal lumen is 
reabsorbed so that BS pool is maintained in the enterohepatic circulation[281, 282]. From these 
findings, it is clear that removal of excess cholesterol is not the main role of BS synthesis in 
cholesterol metabolism in the whole body. There is still 5% of BS pool lost in the feces per cycle 
and humans have 4-5 cycles per day. Quantitatively, the BS loss is compensated by hepatic 
synthesis from cholesterol to maintain BS pool size, which is a significant way to maintain whole 
body cholesterol homeostasis. 
8.2.3 FGF15/19 and BS synthesis 
Fibroblast growth factor 15 (FGF15) is highly expressed in the terminal ileum and is the 
target for FXR. FGF15 protein was demonstrated to suppress BS synthesis in the liver by 
regulating the expression of the genes involved including CYP7A1. It was shown that the 
upregulation of hepatic BS synthesis was associated with low levels of circulating FGF19 in 
humans[283] and an absence of ileal FGF15 mRNA in mice. However, the concentration of this 
protein in the circulation is very low that it is likely that FGF15/19 may not reach the central 
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zone of liver acini. A recent study failed to prove a relation between FGF15/19 levels in 
circulation and CYP7A1 gene expression in rats or rabbits[284]. Therefore, the contribution of 
FGF15/19 to regulation of BS synthesis is still debated compared to other classic pathways (FXR-
SHP mediated suppression of CYP7A1, LXR, insulin) and may vary in different physiological 
conditions. However, in rats with bile duct ligation induced cholestasis model, absence of FGF15 
might explain the upregulation of hepatic CYP7A1 gene expression[285]. But based on the 
reports that in intestine-specific FXR null mice, only slight upregulation of hepatic CYP7A1 
expression was detected at the specific time window during day-light cycle[286], this question is 
still argued. Therefore, it should be appreciated that the regulation of BS synthesis do not by 
definition represent the opposite sides of the same coin but may actually reflect separate other 
processes[275]. 
8.2.4 Summary 
Collectively, in BS and cholesterol homeostasis, liver is always been considered as a 
central place in maintenance. Actually, its role is significant but not without intensive cross-talk 
with other organs. Our findings that liver and intestine work together and cooperatively in 
cholesterol elimination reflect part of this point. The mechanism of how they are functioning 
together needs further exploration. It is largely ignored here because of the space constraints 
that other potentially relevant organs like brain, adrenals also function significantly in lipid 
homeostasis. Hopefully the development of technology will allow the detailed mapping these 
connections. Therefore, working on the cross-talk between liver and intestine on cholesterol 
elimination will be one of the future directions of our studies. 
8.3 Limitations 
To directly measure the cholesterol amount secreted from intestine, TICE measurement 
model is prevalently used in current TICE studies. In this model, bile duct was ligated to cut off 
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bile secretion in order to measure the net cholesterol secretion from intestine. However, as 
discussed in 8.2, many components in the bile including BS is of great importance in regulating 
signals in maintenance of lipid metabolism both in liver and intestine. Cutting off bile secretion 
path would break the enterohepatic circulation of BS and other lipids, and more importantly, 
the cross-talk between the two organs. It is true that in intestine perfusion assay, “man-made” 
cholesterol acceptor including BS (taurocholate) was added for normal cholesterol secretion. 
However, compared to the BS added into intestinal perfusate, the BS constitution in the natural 
bile is significantly more extensive. In humans, the major bile acids are cholic acid (CA) and 
chenodeoxycholic acid (CDCA), which in mice include CA, CDCA and 6-hydroxiylated bile acids, 
mainly muricholic acid (MCA)[287, 288]. And then they are converted to secondary bile acids, 
which in human refer to deoxycholic acid (DCA), ursocholic acid (UCA), ursodeoxycholic acid 
(UDCA) and lithocholic acid (LCA), and in mice include DCA, UCA, UDCA, murideoxycholic acid 
(MDCA) and hyodeoxycholic acid (HDCA).  
The emerging work showed that these transformations are importantly contribute to 
bile acid signaling and even gut microbiota-induced changes in whole body physiology[289-291]. 
For example, compared with mice raised conventionally, the bile acids pool in germ-free mice is 
less “FXR agonistic” because the content of tauro-β-murocholic acids, an endogenouse mouse 
bile acid functioning as FXR antagonist) increased in the bile and intestinal lumen of these 
mice[289, 292]. Based on these, the simple Taurocholate in intestinal perfusate cannot 
represent the bile acids pool that the intestinal lumen are supposed to in normal physiological 
conditions.  
In addition, because of the important host bile acids species difference, it is 
questionable how to translate many of the recent findings including TICE studies from mouse 
models to humans. For example, humans do not synthesize 6-hydroxylated bile acids such as 
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MCA, which makes the mechanisms whereby gut microbiota alterations generated bile acid pool 
with less FXR activation inoperative in humans. 
Therefore, lacking of sufficient and translational bile acids pool in mice models of TICE 
studies is one limitation, which also point out the future direction on the alteration of intestinal 
perfusate. 
8.4 Future direction 
8.4.1 Future directions of experiments 
We found that intestinal total cholesterol excretion was increased in female KO mice 
compared with their WT littermates, indicating another possible G5G8 independent cholesterol 
elimination. Two possible G5G8 independent cholesterol elimination pathways were reported 
before. Annemiek Groen at el. reported that the ATP8B1 deficient maintained a high cholesterol 
output as WT mice did independent of G5G8 activity. The possible mechanism for this 
phenotype is due to the direct extraction of cholesterol from the canalicular membrane by 
hydrophobic bile salts caused by ATP8B1 deficiency[214].  Donna at el. reported a G5G8 
independent mechanism for basal biliary cholesterol secretion in rats during lactation but a 
dependence on G5G8 for maximal biliary cholesterol secretion[213]. The possible transporter 
responsible for increased TICE in female G5G8 KO mice need to be further explored. To achieve 
this goal, we plan to use Microarray at the University of Kentucky Microarray Core Facility as the 
approach to detect the possible transporters or other proteins expressed in the intestinal 
epithelial cells that are involved in accelerating cholesterol efflux in female ABCG5/G8 KO mice. 
Secondly, we found that the differences of biliary cholesterol secretion in male mice 
between genotypes were not as prominent as what was reported before[224] which means that 
the G5G8 KO mice maintained certain level of biliary cholesterol secretion in the absence of 
plant sterol. We maintained our mice on PSF diet instead of chow to protect the mice from 
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sitosterolemia. Thus the possible reason might be the effects of plant sterol accumulation that 
our experimental mice did not have access to on cholesterol secretion. It was reported that 
circulating levels of sitosterol and campesterol are correlated with fractional and absolute 
absorption of dietary cholesterol positively, but are related to whole body cholesterol synthesis 
inversely. Therefore, accumulation of non-cholesterol sterols may account for the very low rates 
of cholesterol synthesis in STSL[217]. Yu et al. found there is approximately 50% decline in 
cholesterols in the livers and plasma of G5G8 KO mice due to low hepatic cholesterol synthesis 
relative to WT mice[218]. Thus it is very likely that blockage of cholesterol synthesis induced by 
accumulation of plant sterol made the role of G5G8 in RCT overestimated. Plant sterol is also 
known as the LXR agonist and FXR antagonists. To figure out the role of plant sterol in the 
ABCG5/G8 independent pathway is one of our future directions. 
We also found a sexually dimorphic cholesterol elimination in both biliary and 
transintestinal pathways. It was reported that the rates of gallstone disease happen in women 
two to three times higher than men[219, 220]. One possible mechanism suggests that estrogen 
increases biliary cholesterol secretion causing cholesterol supersaturation of bile[221]. Besides, 
female mice expressed more ABCG5 and ABCG8 at mRNA levels stimulated by high cholesterol 
synthesis or dietary intake via LXRs[222] in the absence of cholesterol[223]. Therefore, it is 
rational to study the role of estrogen on cholesterol metabolism. 
8.4.2 Future directions of projects 
Like discussed in 8.2 and 8.3, to study the cross-talk between liver and intestine will be 
our overall direction. To achieve this goal, development of a TICE measurement model that is 
more close to the real physiological conditions is required, including to mimic the constitution of 
the real bile. Since biliary cholesterol is also present in intestinal lumen and the role of which on 
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TICE is not known. Therefore, to study the effects of cholesterol content itself in TICE is also a 
significant concern in our future studies. 
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